TATSUO ICHINOHE

Last Updated :2022/10/04

Affiliations, Positions
Research Institute for Radiation Biology and Medicine, Professor
E-mail
nohehiroshima-u.ac.jp
Self-introduction
Clinical Hematology, Hematopoietic Cell Transplantation

Basic Information

Academic Degrees

  • Doctor of Philosophy, Kyoto University

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical internal medicine;Hematology

Affiliated Academic Societies

  • Japanese Society of Internal Medicine
  • Japanese Society of Chemotherapy, 2013
  • Japanese Society for Laboratory Medicine
  • Japanese Association of Germfree Life and Gnotobiology
  • Japanese Society for Histocompatibility and Immunogenetics
  • Japanese Society of Medical Oncology
  • Japanese Society for Hematology
  • Japanese Society of Transfusion Medicine and Cell Therapy
  • Japanese Society for Transplantation and Cellular Therapy, 1997
  • American Society of Hematology, 2003

Educational Activity

Course in Charge

  1. 2022, Undergraduate Education, Year, Clinical diagnosis and treatment II
  2. 2022, Undergraduate Education, Year, Systemic Disease Control
  3. 2022, Undergraduate Education, Intensive, Practice for medical research
  4. 2022, Undergraduate Education, Intensive, Practice of Medicine I
  5. 2022, Undergraduate Education, Intensive, Practice of Medicine II
  6. 2022, Undergraduate Education, First Semester, Internalz Medicine II
  7. 2022, Graduate Education (Doctoral Program) , 1Term, Integrated radiation medical science
  8. 2022, Graduate Education (Master's Program) , Second Semester, General Clinical Medicine and Dentistry
  9. 2022, Graduate Education (Doctoral Program) , 1Term, Principles of Oncology
  10. 2022, Graduate Education (Doctoral Program) , 1Term, Integrated Radiation Medical Science
  11. 2022, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Hematology and Oncology
  12. 2022, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Hematology and Oncology
  13. 2022, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Hematology and Oncology
  14. 2022, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Hematology and Oncology
  15. 2022, Graduate Education (Doctoral Program) , 2Term, Trends of Genome Editing in Medical Science

Research Activities

Academic Papers

  1. Recurrent hyperkalemia in the course of rheumatoid arthritis. A case report., Jpn J Nephrol, 33(8), 811-816, 1991
  2. Antihypertensive effect of intravenous administration of nicardipine hydrochloride in patients with severe hypertension during hemodialysis., Nihon Toseki Igakkai Zasshi, 25(8), 893-896, 1992
  3. Relationship between internal A-V fistula obstruction and plasma level of von Willebrand factor in hemodialysis patients., Nihon Toseki Igakkai Zasshi, 25(4), 361-367, 1992
  4. Involvement of GPIIb-IIIa on human platelets in phosphotyrosine-specific dephosphorylation., BIOCHEMICAL BIOPHYSICAL RESEARCH COMMUNICATION, 194(1), 472-477, 1993
  5. Yataro Yoshida, Tatsuo Ichinohe, Mayumi Dodo, Masaharu Noukawa, Akinori Maeda, Shigeru Oguma, Masao Tajima, Koukichi Yamamoto, Minoru Okuma. Successful bone marrow transplantation with rabbit anti-human thymocyte globulin in aplastic anemia. Report of a case previously treated with equine anti-human lymphocyte globulin.Int J Hematol. 1994; 60(1):79-83. , 19940101
  6. Takafumi Ishibashi, Tatsuo Ichinohe, Tateo Sugiyama, Hiroshi Takayama, Kouichi Chitani, Minoru Okuma. Functional significance of platelet membrane glycoprotein p62 (GP VI), a putative collagen receptor. Int J Hematol 1995; 62(2):107-115., 19950801
  7. Functional significance of platelet membrane glycoprotein p62 (GP VI), a putative collagen receptor, 62(2), 107-115, 199508
  8. ★, Tatsuo Ichinohe, Hiroshi Takayama, Yasuharu Ezumi, Shigeru Yanagi, Hirohei Yamamura, Minoru Okuma: Cyclic AMP-insensitive activation of c-Src and Syk protein-tyrosine kinases through platelet membrane glycoprotein VI. J Biol Chem. 1995; 270(47):28029-28036. , 19951101
  9. Platelet Activation Through Membrane Glycoprotein VI, 7(3), 251-254, 19960601
  10. T Cell Non-depleted Bone Marrow Transplantation for Primary Refractory Erythroleukemia Using a Partially HLA-mismatched Related Donor, Rinsho Ketsueki, 40(7), 581-586, 19990730
  11. ★, Tatsuo Ichinohe, Hiroshi Takayama, Yasuharu Ezumi, Morio Arai, Naomasa Yamamoto, Hoyu Takahashi, Minoru Okuma: Collagen-stimulated activation of Syk but not c-Src is severely compromised in human platelets lacking membrane glycoprotein VI. J Biol Chem. 1997; 272(1):63-68. , 272(1), 63-68, 19970101
  12. C.Graham Knight, Laurence F. Morton, David J. Onley, Anthony R. Peachy, Tatsuo Ichinohe, Minoru Okuma, Richard W. Farndale, Michael J. Barnes. Collagen-platelet interaction: Gly-Pro-Hyp is uniquely specific for platelet GPVI and mediates platelet activation by collagen. Cardiovasc Res. 1999; 41(2):450-457. , 19990201
  13. Shigehisa Tamaki, Tatsuo Ichinohe, Keitaro Matsuo, Nobuyuki Hamajima, Noriyuki Hirabayashi, Hiroo Dohy: Superior survival of blood and marrow stem-cell recipients given maternal grafts over recipients given paternal grafts. Bone Marrow Transplant. 2001; 28(4):375-380. , 20010801
  14. Ai Kotani, Takayuki Ishikawa, Yumi Matsumura, Tatsuo Ichinohe, Hitoshi Ohno, Toshiyuki Hori, Takashi Uchiyama. Correlation of peripheral blood OX40+ T cells with chronic graft-versus-host disease in patients who underwent allogeneic hematopoietic stem cell transplantation. Blood. 2001; 98(10):3162-3164. , 20011101
  15. Long-term Feto-Maternal Microchimerism : Nature's Hidden Clue for Alternative Donor Hematopoietic Cell Transplantation?, Int J Hematol, 76(3), 229-237, 20021001
  16. Ai Kotani, Atsushi Takahashi, Hikari Koga, Rinpei Morita, Hidenao Fukuyama, Tatsuo Ichinohe, Takyuki Ishikawa, Toshiyuki Hori, Takashi Uchiyama. Myasthenia gravis after allogeneic bone marrow transplantation treated with mycophenolate mofetil monitored by peripheral blood OX40+CD4+ T cells. Eur J Haematol. 2002; 69(5-6):318-320. , 20021101
  17. Takashi Kobayashi, Shingo Yamamoto, Eijiro Nakamura, Toshiyuki Kamato, Yoshiyuki Kakehi, Osamu Ogawa, Noriyuki Ito, Takuo Fukuyama, Masakatsu Hishizawa, Tatsuo Ichinohe. Dose-intensive chemotherapy with syngeneic peripheral blood stem cell support for poor risk germ cell tumor of extragonadal origin: a case report. Jpn J Clin Oncol. 2002; 32(1):33-34. , 20020101
  18. ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ATL, 50, 253-262, 20030101
  19. Umeda K, Adachi S, Ishihara H, Higashi Y, Shiota M, Wananabe KI, Hishizawa M, Ichinohe T, Kitoh T, Maruya E, Saji H, Uchiyama T, Nakahata T. Successful T-cell-replete peripheral blood stem cell transplantation from HLA-haploidentical microchimeric mother to daughter with refractory acute lymphoblastic leukemia using reduced-intensity conditioning. Bone Marrow Transplant 2003; 31(11):1061-1063., 20030601
  20. Kitawaki T, Kadowaki N, Ishikawa T, Ichinohe T, Uchiyama T. Compromised recovery of natural interferon-alpha/beta-producing cells after allogeneic hematopoietic stem cell transplantation complicated by acute graft-versus-host-disease and glucocorticoid administration. Bone Marrow Transplant. 2003; 32(2):187-194., 20030701
  21. Current status of reduced-intensity stem cell transplantation;Survey in the Kinki area, 44(6), 407-413, 20030630
  22. Current status of reduced-intensity stem cell transplantation; Survey in the Kinki area, Rinsho Ketsueki, 44(6), 407-413, 2003
  23. ★, Tatsuo Ichinohe, Takashi Uchiyama, Chihiro Shimazaki, Keitaro Matsuo, Shigehisa Tamaki, Masayuki Hino, Arata Watanabe, Motohiro Hamaguchi, Souichi Adachi, Hisashi Gondo, Nobuhiko Uoshima, Takao Yoshihara, Kazuo Hatanaka, Hiroshi Fujii, Keisei Kawa, Kazunobu Kawanishi, Koji Oka, Hideo Kimura, Mitsuru Itoh, Takeshi Inukai, Etsuko Maruya, Hiroh Saji, Yoshihisa Kodera. Feasibility of HLA-haploidentical hematopoietic stem-cell transplantation between non-inherited maternal antigen (NIMA)-mismatched family members linked with long-term feto-maternal microchimerism. Blood. 2004; 104(12):3821-3828. EPub 2004 Jul 27., BLOOD, 20041201
  24. Yoshihisa Kodera, Tetsuya Nishida, Tatsuo Ichinohe, Hiroh Saji. Human leukocyte antigen haploidentical hematopoietic stem cell transplantation: indications and tentative outcomes in Japan. Semin Hematol. 2005; 42(2):112-118., 20050401
  25. Narimatsu H, Wake A, Miura Y, Tanaka H, Matsumura T, Takagi S, Kato D, Myojo T, Kusumi E, Masuoka K, Miyakoshi S, Morinaga S, Saji H, Ichinohe T, Taniguchi S. Successful engraftment in crossmatch-positive HLA-mismatched peripheral blood stem cell transplantation after depletion of antidonor cytotoxic HLA antibodies with rituximab and donor platelet infusion. Bone Marrow Transplant. 2005; 36(6):555-556. , 20050901
  26. Tatsuo Ichinohe, Takanori Teshima, Ken-ichi Matsuoka, Etsuko Maruya, Hiroh Saji. Fetal-maternal microchimerism: impact on hematopoietic stem cell transplantation. Curr Opin Immunol. 2005; 17(5):546-552. , 20051001
  27. Kojima R, Kami M, Kanda Y, Kusumi E, Kishi Y, Tanaka Y, Yoshioka S, Morishima S, Fujisawa S, Mori SI, Kasai M, Hatanaka K, Tajima K, Kasai M, Mitani K, Ichinohe T, Hirai H, Taniguchi S, Sakamaki H, Harada M, Takaue Y. Comparison between reduced intensity and conventional myeloablative allogeneic stem-cell transplantation in patients with hematologic malignancies aged between 50 and 59 years. Bone Marrow Transplant. 2005; 36(8):667-674., 20051001
  28. Takanori Teshima, Ken-ichi Matsuoka, Tatsuo Ichinohe. Impact of fetal-maternal tolerance in hematopoietic stem cell transplantation. Arch Immunol Ther Exp (Warsz). 2006; 54(3):165-172. EPub 2006 May 2., 20060501
  29. Sung-Won Kim, Tetsuya Tanimoto, Noriyuki Hirabayashi, Seiichi Goto, Masahiro Kami, Satoshi Yoshioka, Toshiki Uchida, Kenji Kishi, Yuji Tanaka, Akio Kohno, Masaharu Kasai, Masakazu Higuchi, Masanobu Kasai, Shin-ichiro Mori, Takahiro Fukuda, Koji Izutsu, Hiroshi Sao, Takayuki Ishikawa, Tatsuo Ichinohe, Kengo Takeuchi, Kinuko Tajima, Ryuji Tanosaki, Mine Harada, Shuichi Taniguchi, Kensei Tobinai, Tomomitsu Hotta, Yoichi Takaue. Myeloablative allogeneic hematopoietic stem cell transplantation for non-Hodgkin lymphoma: a nationwide survey in Japan. Blood. 2006; 108(1):382-389. EPub 2006 Mar 7., 20060601
  30. Ken-ichi Matsuoka, Tatsuo Ichinohe, Daigo Hashimoto, Shoji Asakura, Mitsune Tanimoto, Takanori Teshima. Fetal tolerance to maternal antigens improves the outcome of allogeneic bone marrow transplantation by a CD4+CD25+ T-cell-dependent mechanism. Blood., 20060901
  31. Impact of fetal-maternal tolerance in hematopoietic stem cell transplantation, ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 54(3), 165-172, 2006
  32. Clinical significance of the "NIMA effect" in HLA-mismatched hematopoietic stem cell transplantation, 47(7), 618-625, 20060730
  33. Clinical significance of fetal-maternal immunological tolerance in HLA-mismatched allogeneic stem cell transplantation, Journal of germfree life and gnotobiology, 36(1), 24-27, 20060901
  34. Kazue Arimoto, Norimitsu Kadowaki, Takayuki Ishikawa, Tatsuo Ichinohe, Takashi Uchiyama. FOXP3 expression in peripheral blood rapidly recovers and lacks correlation with the occurrence of graft-versus-host disease after allogeneic stem cell transplantation. Int J Hematol. 2007; 85(2):154-162., 20070201
  35. FOXP3 Expression in Peripheral Blood Rapidly Recovers and Lacks Correlation with the Occurrence of Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation, Int J Hematol, 85(2), 154-162, 20070215
  36. Sasaki K, Yamashita K, Miyoshi T, Furukawa Y, Kimura T, Kita T, Ichinohe T, Ishikawa T, Sasada M, Uchiyama T. Analysis of serum angiogenic factors in a young multiple myeloma patient with high-output cardiac failure. Int J Hematol. 2007; 86(1): 72-76., 20070701
  37. Chonabayashi K, Kondo T, Tanaka Y, Ichinohe T, Ishikawa T, Uchiyama T. Sustained complete remission of refractory enteropathy-type T-cell lymphoma following reduced-intensity unrelated cord blood transplantation. Bone Marrow Transplant 2007; 40(9): 905-906., 20071101
  38. Ryo Yamamoto, Akifumi Takaori-Kondo, Junya Kanda, Kazunori Imada, Tatsuo Ichinohe, Takayuki Ishikawa, Katsuyuki Ohmori, Takashi Uchiyama. Durable remission of large B-cell lymphoma transformed from lymphoplasmacytic lymphoma/Waldenström macroglobulinemia successfully treated with sequential immunochemotherapy followed by reduced-intensity allogeneic stem cell transplantation.Bone Marrow Transplant. 2008; 41(6):591-593. EPub 2007 Dec10., 20071201
  39. Reversible cardiomyopathy associated with multicentric Castleman disease: Successful treatment with tocilizumab, an anti-interleukin 6 receptor antibody, INTERNATIONAL JOURNAL OF HEMATOLOGY, 85(3), 207-211, 2007
  40. Analysis of serum angiogenic factors in a young multiple myeloma patient with high-output cardiac failure, INTERNATIONAL JOURNAL OF HEMATOLOGY, 86(1), 72-76, 2007
  41. Breast-feeding mediates feto-maternal tolerance and improves outcome of allogeneic bone marrow transplantation, BLOOD, 110(11), 644A-644A, 2007
  42. Monitoring of serum hepcidin-25 in multicentric Castleman's disease patients treated with tocilizumab, an anti-interleukin-6 receptor antibody, BLOOD, 110(11), 1077A-1077A, 2007
  43. Long-term survival after HLA-haploidentical stem cell transplantation, from non-inherited maternal antigen-mismatched family donors: Impact of chronic graft-versus-host disease, BLOOD, 110(11), 349B-349B, 2007
  44. Similar background of graft-versus-host disease (GVHD) following allogeneic blood and marrow transplantation (Tx) in Korean and Japanese populations allows a uniform foundation to perform large-scale clinical studies in the region, BLOOD, 110(11), 330B-330B, 2007
  45. Reappraisal of gastrointestinal decontamination as a practice in preventing infectious complications after hematopoietic stem-cell transplantation, Journal of germfree life and gnotobiology, 37(1), 18-22, 20070601
  46. Saito T, Yoshioka S, Iinuma Y, Takakura S, Fujihara N, Ichinohe T, Ishikawa T, Uchiyama T, Ichiyama S. Effects on spectrum and susceptibility patterns of isolates causing bloodstream infection by restriction of fluoroquinolone prophylaxis in a hematology-oncology unit. Eur J Clin Microbiol Infect Dis. 2008; 27(3):219-216., 20080301
  47. Toshio Kitawaki, Norimitsu Kadowaki, Tadakazu Kondo, Takayuki Ishikawa, Tatsuo Ichinohe, Satoshi Teramukai, Masanori Fukushima, Yasunari Kasai, Taira Maekawa, Takashi Uchiyama. Potential of dendritic-cell immunotherapy for relapse after allogeneic hematopoietic stem cell transplantation, shown by WT1 peptide- and keyhole-limpet-hemocyanin-pulsed, donor-derived dendritic-cell vaccine for acute myeloid leukemia. Am J Hematol. 2008; 83(4): 315-317., 20080401
  48. Muramatsu H, Kimura S, Ichinohe T, Ashihara E, Ishikawa T, Maekawa T, Uchiyama T. Consulting clinic for related family donors in hematopoietic stem cell transplantation. Bone Marrow Transplant. 2008; 41(12):1073-1075. , 20080601
  49. Potential of dendritic cell immunotherapy for relapse after allogeneic hematopoietic stem cell transplantation, shown by WT1 peptide- and keyhole limpet hemocyanin-pulsed, donor-derived dendritic cell vaccine for acute myeloid leukemia, AMERICAN JOURNAL OF HEMATOLOGY, 83(4), 315-317, 2008
  50. Clinical Significance of Serum Hepcidin-25 Levels on Early Treatment-Related Complications after Hematopoietic Stem Cell Transplantation, BLOOD, 112(11), 424-424, 2008
  51. Reactivation of Human Herpes Virus 6 (HHV6) during Hematopoietic Stem Cell Transplantation: Risk Factor Analysis of HHV6 Encephalitis and Survival, BLOOD, 112(11), 775-775, 2008
  52. Epstein-Barr virus-associated B cell lymphoproliferative disorder complicated in adult T-cell leukemia, Rinsho Ketsueki, 49(4), 263-269, 20080430
  53. Selection of hematopoietic stem cell source, 57(4), 723-729, 200804
  54. Allogeneic hematopoietic stem cell transplantation from an HLA-haploidentical related donor based on feto-maternal tolerance, Journal of Okayama Medical Association, 120(1), 23-28, 20080501
  55. Junya Kanda, Tatsuo Ichinohe, Keitaro Matsuo, Richard J. Benjamin, Thomas R. Klumpp, Primoz Rozman, Neil Blumberg, Jayesh Mehta, Sang-Kyun Sohn, Takashi Uchiyama. Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: Individual patient data-based meta-analysis of cohort studies. Transfusion. 2009; 49(4):624-635. EPub 2009 Jan 2., 20090101
  56. Kazutoshi Aoyama, Motoko Koyama, Ken-ichi Matsuoka, Daigo Hashimoto, Tatsuo Ichinohe, Mine Harada, Koichi Akashi, Mitsune Tanimoto, Takanori Teshima. Improved outcome of allogeneic bone marrow transplantation due to breast-feeding-induced tolerance to maternal antigens. Blood. 2009; 113(8): 1829-1833. EPub 2009 Jan 5., 20090101
  57. Kanda J, Ichinohe T, Shimazaki C, Hamaguchi M, Watanabe A, Ishida H, Yoshihara T, Morimoto A, Uoshima N, Adachi S, Inukai T, Sawada A, Oka K, Itoh M, Hino M, Maruya E, Saji H, Uchiyama T, Kodera Y. Long-term survival after HLA-haploidentical stem cell transplantation from non-inherited maternal antigen-mismatched family donors: impact of chronic graft-versus-host disease. Bone Marrow Transplant. 2009; 44(5): 327-329. EPub 2009 Feb 16., 20090101
  58. Takashi Saito, Akifumi Takaori-Kondo, Masaharu Tashima, Kouhei Yamashita, Yoshitsugu Iinuma , Shunji Takakura, Miki Nagao, Tatsuo Ichinohe, Takayuki Ishikawa, Takashi Uchiyama, Satoshi Ichiyama. Successful treatment with intravenous colistin for sinusitis, orbital cellulites, and pneumonia caused by multidrug-resistant metallo-beta-lactamase- producing Pseudomonas aeruginosa in a patient with acute myeloid leukemia.Int J Hematol. 2009; 89(5): 689-692. EPub 2009 Mar24, 20090301
  59. Chisato Mizumoto, Junya Kanda, Tatsuo Ichinohe, Takayuki Ishikawa, Masashi Matsui, Norimitsu Kadowaki, Tadakazu Kondo, Kazunori Imada, Masakatsu Hishizawa, Hiroshi Kawabata, Momoko Nishikori, Kouhei Yamashita, Akifumi Takaori-Kondo, Toshiyuki Hori, Takashi Uchiyama. Mycophenolate mofetil combined with tacrolimus and minidose methotrexate after unrelated donor bone marrow transplantation with reduced-intensity conditioning. Int J Hematol. 2009; 89(4): 538-545. EPub 2009 Apr 11., 20090401
  60. Junya Kanda, Chisaki Mizumoto, Hiroshi Kawabata, Tatsuo Ichinohe, Hideyuki Tsuchida, Naohisa Tomosugi, Keitaro Matsuo, Kouhei Yamashita, Tadakazu Kondo, Takayuki Ishikawa, Takashi Uchiyama. Clinical significance of serum hepcidin levels on early infectious complications in allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2009; 15(8):956-962. , 20090401
  61. Ryo Yamamoto, Momoko Nishikori, Masahru Tashima, Tomomi Sakai, Tatsuo Ichinohe, Akifumi Takaori-Kondo, Katsuyuki Ohmori, Takashi Uchiyama. B7-H1 expression is regulated by MEK/ERK signaling pathway in anaplastic large cell lymphoma and Hodgkin lymphoma. Cancer Sci. 2009; 100(11): 2093-2100. EPub 2009 Aug 1., 20090801
  62. Junya Kanda, Keitaro Matsuo, Tadakazu Kawase, Takeshi Suzuki, Tatsuo Ichinohe, Masao Seto, Yasuo Morishima, Kazuo Tajima, Tanaka Hideo. Association of alcohol intake and smoking with malignant lymphoma risk in Japanese: A hospital-based case-control study at Aichi Cancer Center. Cancer Epidemiol Biomarkers Prev. 2009; 18(9): 2436-2441. EPub 2009 Sep 1., 20090901
  63. Kanda J, Ichinohe T, Saito T, Yamashita K, Kondo T, Ishikawa T, Ichiyama S, Uchiyama T. Impact of discontinuing fluoroquinolone prophylaxis after allogeneic marrow or peripheral blood SCT with myeloablative conditioning. Bone Marrow Transplant. 2010; 45(8):1369-1371. EPub 2009 Dec 7. , 20091201
  64. Improved outcome of allogeneic bone marrow transplantation due to breastfeeding-induced tolerance to maternal antigens, BLOOD, 113(8), 1829-1833, 2009
  65. Mycophenolate mofetil combined with tacrolimus and minidose methotrexate after unrelated donor bone marrow transplantation with reduced-intensity conditioning, INTERNATIONAL JOURNAL OF HEMATOLOGY, 89(4), 538-545, 2009
  66. Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies, TRANSFUSION, 49(4), 624-635, 2009
  67. Successful treatment with intravenous colistin for sinusitis, orbital cellulites, and pneumonia caused by multidrug-resistant metallo-beta-lactamase-producing Pseudomonas aeruginosa in a patient with acute myeloid leukemia, INTERNATIONAL JOURNAL OF HEMATOLOGY, 89(5), 689-692, 2009
  68. Clinical Significance of Serum Hepcidin Levels on Early Infectious Complications in Allogeneic Hematopoietic Stem Cell Transplantation, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 15(8), 956-962, 2009
  69. Association of Alcohol Intake and Smoking with Malignant Lymphoma Risk in Japanese: A Hospital-Based Case-Control Study at Aichi Cancer Center, CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 18(9), 2436-2441, 2009
  70. B7-H1 expression is regulated by MEK/ERK signaling pathway in anaplastic large cell lymphoma and Hodgkin lymphoma, CANCER SCIENCE, 100(11), 2093-2100, 2009
  71. Clinical Significance of Severity and Subcategory of Chronic GVHD Evaluated by NIH Consensus Criteria, BLOOD, 114(22), 874-874, 2009
  72. Junya Kanda, Keitaro Matsuo, Takeshi Suzuki, Satoyo Hosono, Hidemi Ito, Tatsuo Ichinohe, Masao Seto, Yasuo Morishima, Kazuo Tajima, Hideo Tanaka. Association between obesity and the risk of malignant lymphoma in Japanese: A case-cotrol study. Int J Cancer. 2010; 126(10):2416-2425. , 20100501
  73. Koji Nagafuji, Keitaro Matsuo, Takanori Teshima, Shin-ichi Mori, Hisahi Sakamaki, Michihiro Hidaka, Hiroyasu Ogawa, Yoshihisa Kodera, Yoshinobu Kanda, Atsuo Maruta, Takehiko Mori, Fumiaki Yoshiba, Tatsuo Ichinohe, Masanobu Kasai, Yoshifusa Takatsuka, Kohmei Kubo, Hiroshi Sao, Yoshiko Atsuta, Ritsuro Suzuki, Takashi Yoshida, Masahiro Tsuchida, Mine Harada. Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia: a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry. Int J Hematol 2010; 91(5):855-864. EPub 2010 May 14., INTERNATIONAL JOURNAL OF HEMATOLOGY, 91(5), 855-864, 20100601
  74. Kosuke Ueda, Matsui Hiroyuki, Tomohiro Watanabe, Junya Seki, Tatsuo Ichinohe, Yoshihisa Tsuji, Kayoko Matsumura, Yugo Sawai, Hiroshi Ido, Yoshihide Ueda, Tsutomu Chiba. Spontaneous rupture of liver plasmacytoma mimicking hepatocellular carcinoma. Intern Med. 2010; 49 (7):653-657., 20100801
  75. Tatsuo Ichinohe. Long-term fetal-maternal microchimerism revisited: microchimeirsm and tolerance in hematopoietic stem cell transplantation. Chimerism. 2010; 1(1): 39-43., 20100701
  76. Kazunari Aoki, Shinichi Kotani, Tatsuo Ichinohe, Tadakazu Kondo, Takayuki Ishikawa. Acute renal failure associated with systemic polyoma BK virus activation in a patient with periheral T-cell lymphoma. Int J Hematol. 2010;92(4):638-641., 20101101
  77. Yoshihide Ueda, Hiroyuki Marusawa, Tatsuo Ichinohe, Norimitsu Kadowaki, Takashi Uchiyama, Tsutomu Chiba. Effective treatment for de novo hepatitis B with nucleoside analogue in patients with hematological malignancies. Am J Hematol. 2009; 84(5): 315-316., 20101201
  78. ★, Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study, BLOOD, 116(8), 1369-1376, 2010
  79. Spontaneous Rupture of Liver Plasmacytoma Mimicking Hepatocellular Carcinoma, INTERNAL MEDICINE, 49(7), 653-657, 2010
  80. Association between obesity and the risk of malignant lymphoma in Japanese: a case-control study, INTERNATIONAL JOURNAL OF CANCER, 126(10), 2416-2425, 2010
  81. Acute renal failure associated with systemic polyoma BK virus activation in a patient with peripheral T-cell lymphoma, INTERNATIONAL JOURNAL OF HEMATOLOGY, 92(4), 638-641, 2010
  82. Impact of Serum Ferritin Levels on the Incidence of Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation., BLOOD, 116(21), 535-535, 2010
  83. CONSULTING CLINIC FOR RELATED FAMILY DONORS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION, 56(1), 68-71, 20100225
  84. Takashi Saito, Tatsuo Ichinohe, Junya Kanda, Miki Nagao, Shunji Takakura, Yutaka Ito, Yoshitsugu Iinuma, Kouhei Yamashita, Tadakazu Kondo, Takayuki Ishikawa, Takashi Uchiyama, Satoshi Ichiyama. Historical cohort study of the efficacy and safety of piperacillin/tazobactam versus fourth-generation cephalosporins for empirical treatment of febrile neutropenia in patients with hematological malignancies. Int J Clin Med. 2011; 2(1):18-22., 20110101
  85. Kanda J, Mizumoto C, Ichinohe T, Kawabata H, Saito T, Yamashita K, Kondo T, Takakura S, Ichiyama S, Uchiyama T, Ishikawa T. Pretransplant serum ferritin and C-reactive protein as predictive factors for early bacterial infection after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2011Feb 2; 46(2):208-216. 2010 May 3. [EPub ahead of print.], 20110201
  86. Takayuki Sato, Tatsuo Ichinohe, Junya Kanda, Kouhei Yamashita, Tadakazu Kondo, Takauki Ishikawa, Takashi Uchiyama, Akifumi Takaori-Kondo. Clinical significance of subcategory and severity of chronic graft-versus-host disease evaluated by National Institutes of Health consensus criteria. Int J Hematol. 2011;93(4):532-541., 20110401
  87. Clinical significance of subcategory and severity of chronic graft-versus-host disease evaluated by National Institutes of Health consensus criteria, INTERNATIONAL JOURNAL OF HEMATOLOGY, 93(4), 532-541, 2011
  88. Case report: A case of acute abdomen as an atypical manifestation of disseminated varicella-zoster virus infection, 65(12), 1005-1008, 201111
  89. Imatinib-resistant BCR-ABL Mutants, 66(11), 2587-2593, 201111
  90. Takeshi Ito, Kenichiro Akagi, Kentaro Akagi, Tadakazu Kondo, Hiroshi Kawabata, Tatsuo Ichinohe, Akifumi Takaori-Kondo. Splenic irradiation as a component of a reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in myelofibrosis with massive splenomegaly. Tohoku J Exp Med. 2012; 228(4):295-299. , 20120401
  91. Hidekazu Itamura, Noriyasu Fukushima, Seiji Kondo, Chisako Urata, Mariko Yoshimura, Masako Yokoo, Masaru Ide, Takashi Hisatomi, Yasushi Kubota, Eisaburo Sueoka, Tatsuo Ichinohe, Shinya Kimura. Successful Reduced-intensity umbilical cord blood transplantation for fulminant hemophagocytic syndrome in an adult with pre-existing rheumatoid arthritis and autoimmune hemolytic anemia.Leuk Lymphoma. 2012 Nov;53(11):2307-2309 [EPub 2012 Apr19], 20121101
  92. ★, Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study, BLOOD, 119(9), 2141-2148, 2012
  93. Successful reduced-intensity umbilical cord blood transplant for fulminant hemophagocytic syndrome in an adult with pre-existing rheumatoid arthritis and autoimmune hemolytic anemia, LEUKEMIA & LYMPHOMA, 53(11), 2307-2309, 2012
  94. Splenic Irradiation as a Component of a Reduced-Intensity Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Myelofibrosis with Massive Splenomegaly, TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 228(4), 295-299, 2012
  95. Combination Effects of Nilotinib and Zoledronic Acid On Chronic Myeloid Leukemia Are Canceled in the Co-Culture System Which Mimic the Bone Marrow Microenvironment, BLOOD, 120(21), 2012
  96. Expression of C/EBP beta in Bone Marrow Mesenchymal Stem Cells Is Mandatory for Early-Stage B Cell Lymphopoiesis, BLOOD, 120(21), 2012
  97. Myeloproliferative neoplasms (including chronic myeloid leukemia), 53(1), 59-70, 20120130
  98. Immunoregulatory activities of immunodulatory drugs (IMiDs), 242(13), 1111-1115, 20120929
  99. Administration of Once-Daily Tacrolimus Extended-Release Formulation in Allogeneic Stem Cell Transplantation, Journal of Hematopoietic Cell Transplantation, 1(2), 59-65, 2012
  100. Souichiro Sakamoto, Hiroshi Kawabata, Junya Kanda, Tatsuki Uchiyama, Chisaki Mizumoto, Tadakazu Kondo, Kouhei Yamashita, Tatsuo Ichinohe, Takayuki Ishikawa, Norimitsu Kadowaki, Akifumi Takaori-Kondo. Differing impacts of pretransplant serum ferritin and C-reactive protein levels on the incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2013 Jan; 97(1):109-16., 20130101
  101. on behalf of the Donor/Source Working Group and HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.Unrelated cord blood transplantation vs. related transplantation with HLA 1-antigen mismatch in the graft-versus-host direction., Leukemia, 27(2), 286-294, 20130201
  102. HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation., Biol Blood Marrow Transplant, 19(2), 247-254, 20130201
  103. Yoshinobu Kanda, Junya Kanda, Yoshiko Atsuta, Yoshinobu Maeda, Tatsuo Ichinohe, Kazuteru Ohashi, Takahiro Fukuda, Koichi Miyamura, Hiromitsu Iida, Takehiko Mori, Koji Iwato, Tetsuya Eto, Keisei Kawa, Satoshi Morita, Yasuo Morishima. Impact of a single HLA allele mismatch on the outcome of unrelated bone marrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLA Working Group of the Japan Society for Blood and Marrow Transplantation. Br J Haematol. 2013 May;161(4):566-77.[EPub 2013 Mar 4], 20130501
  104. Makoto Hirokawa, Takahiro Fukuda, Hideki Akiyama, Michihiro Hidaka, Tatsuo Ichinohe, Koji Iwato, Heiwa Kanamori, Makoto Murata, Toru Sakura, Masahiro Imamura, Soichi Adachi, Ritsuro Suzuki, Yasuo Morishima and Hisashi Sakamaki, for The PRCA Collaborative Study Group. Efficacy and long-term outcome of treatment for pure red cell aplasia (PRCA) following allogeneic hematopoietic stem cell transplantation (HSCT) from major ABO-incompatible donors. Biol Blood Marrow Transplant. 2013 Jul;19(7):1026-32. [EPub 2013 Apr 10], 20130701
  105. Miura Y, Yoshioka S, Yao H, Takaori-Kondo A, Maekawa T, Ichinohe T. Chimerism of bone marrow mesenchymal stem/stromal cells in allogneic hematopoietic cell transplantation: is it clinically relevant? Chimerism 2013 Jul;4(3):78-83., 20130701
  106. Yoshihara M, Itamura H, Fukushima N, Itoh M, Furukawa K, Nagatomo D, Kamachi K, Kitamura H, Shindo T, Kubota Y, Sueoka E, Morita S, Ichinohe T, Kimura S. Therapeutic management in cardiac lymphoma. Leuk Lymphoma. 2013 Sep 3 Epub ahead of print., 20130901
  107. Yoshioka S, Miura Y, Yao H, Satake S, Hayashi Y, Tamura A, HIshita T, Ichinohe T, Hirai H, Takaori-Kondo A, Maekawa T. Stem Cells. 2013 Oct 1 EPub ahead of print., 20131001
  108. Differing impacts of pretransplant serum ferritin and C-reactive protein levels on the incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation, INTERNATIONAL JOURNAL OF HEMATOLOGY, 97(1), 109-116, 2013
  109. Impact of the Direction of HLA Mismatch on Transplantation Outcomes in Single Unrelated Cord Blood Transplantation, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 19(2), 247-254, 2013
  110. Impact of a single human leucocyte antigen (HLA) allele mismatch on the outcome of unrelated bone marrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLA Working Group of the Japan Society for Blood and Marrow Transplantation, BRITISH JOURNAL OF HAEMATOLOGY, 161(4), 566-577, 2013
  111. Efficacy and Long-Term Outcome of Treatment for Pure Red Cell Aplasia after Allogeneic Stem Cell Transplantation from Major ABO-Incompatible Donors, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 19(7), 1026-1032, 2013
  112. MANAGEMENT OF TRANSFUSIONAL IRON OVERLOAD, 59(1), 73-78, 20130228
  113. Hematopoietic cell transplantation crossing the HLA barrier, 45(11), 516-519, 201310
  114. Long-term remission in patients with plasma cell myeloma after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation::A 10-year single-center experience, Journal of Hematopoietic Cell Transplantation, 2(1), 25-31, 2013
  115. A meeting report: 16th International HLA and Immunogenetics Workshop, MHC, 20(1), 57-61, 2013
  116. Role of HLA compatibility in unrelated cord blood transplantation, MHC, 20(2), 101-107, 2013
  117. Kanda Y, Kanda J, Atsuta Y, Fuji S, Maeda Y, Ichinohe T, Takanashi M, Ohashi K, Fukuda T, Miyamura K, Mori T, Sao H, Kobayashi N, Iwato K, Sawada A, Mori S; HLA working group of the Japan Society for Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2014 Jan 10 EPub ahead of print. , 20140101
  118. CCAAT/Enhancer-Binding Protein beta Expressed by Bone Marrow Mesenchymal Stromal Cells Regulates Early B-Cell Lymphopoiesis, STEM CELLS, 32(3), 730-740, 201403
  119. Changes in the Clinical Impact of High-Risk Human Leukocyte Antigen Allele Mismatch Combinations on the Outcome of Unrelated Bone Marrow Transplantation, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 20(4), 526-535, 201404
  120. Impact of HLA allele mismatch on the clinical outcome in serologically matched related hematopoietic SCT, BONE MARROW TRANSPLANTATION, 49(9), 1187-1192, 201409
  121. Parathyroid Hormone Enhances Hematopoietic Expansion Via Upregulation of Cadherin-11 in Bone Marrow Mesenchymal Stromal Cells, STEM CELLS, 32(8), 2245-2255, 2014
  122. A Novel Frameshift Mutation in Exon 4 Causing a Deficiency of High-molecular-weight Kininogen in a Patient with Splenic Infarction, INTERNAL MEDICINE, 53(3), 253-257, 2014
  123. Impact of Conditioning Intensity with or without Total Body Irradiation on Acute Graft-Versus-Host Disease and Clinical Outcomes, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 20(2), S275-S276, 2014
  124. Therapeutic management in cardiac lymphoma, LEUKEMIA & LYMPHOMA, 55(5), 1215-1217, 2014
  125. Concurrent administration of darbepoetin alfa, cyclosporine A, and prednisolone is useful for T cell large granular lymphocyte leukemia associated with myelodysplastic syndrome complicated by Coombs-negative hemolytic anemia, ANNALS OF HEMATOLOGY, 93(11), 1937-1939, 2014
  126. Effects of Irradiation on the Functional Characteristics of Human Bone Marrow Mesenchymal Stromal/Stem Cells, BLOOD, 124(21), 2014
  127. Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia Transformed from Ph-Negative Myeloproliferative Neoplasm: A Study from the Adult AML Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT), BLOOD, 124(21), 2014
  128. Long-Term Survival with High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation and Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm: A Retrospective Registry Study from the Japan Society for Hematopoietic Cell Transplantation, BLOOD, 124(21), 2014
  129. Impact of Low-Dose TBI on Outcome of Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation from HLA Identical Sibling for Acute Myeloid Leukemia, BLOOD, 124(21), 2014
  130. Concurrent administration of darbepoetin alfa, cyclosporine A, and prednisolone is useful for T cell large granular lymphocyte leukemia associated with myelodysplastic syndrome complicated by Coombs-negative hemolytic anemia., Concurrent administration of darbepoetin alfa, cyclosporine A, and prednisolone is useful for T cell large granular lymphocyte leukemia associated with myelodysplastic syndrome complicated by Coombs-negative hemolytic anemia., 93(11), 2014
  131. Immunomodulatory drugs (IMiDs), 72(6), 1130-1135, 201406
  132. Systemic approaches to organ-specific complications after allogeneic hematopoietic cell transplantation, Rinsho Ketsueki, 55(10), 2125-2135, 201410
  133. POSITIVE CONVERSION OF ANTI-HBS AND ANTI-HBC ANTIBODIES TRANSFERRED TO A PEDATRIC PATIENT FROM BLOOD TRANSFUSION DONORS: A CASE STUDY, Journal of the Japan Society of Blood Transfusion, 60(4), 533-538, 2014
  134. A systematic approach to organ-specific complications after allogeneic hematopoietic cell transplantation, Rinsho Ketsueki, 55(10), 2125-2135, 2014
  135. Hematopoietic cell transplantation in Japan: Nationwide Survey 2013, Rinsho Ketsueki, 55(12), 2381-2399, 2014
  136. Impact of HLA Mismatch Direction on the Outcome of Unrelated Bone Marrow Transplantation: A Retrospective Analysis from the Japan Society for Hematopoietic Cell Transplantation, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 21(2), 305-311, 201502
  137. Biological significance of HLA locus matching in unrelated donor bone marrow transplantation, BLOOD, 125(7), 1189-1197, 20150212
  138. Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation, BONE MARROW TRANSPLANTATION, 50(4), 559-565, 201504
  139. Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm, BLOOD, 125(23), 3559-3562, 20150604
  140. A single high-resolution HLA mismatch has a similar adverse impact on the outcome of related hematopoietic stem cell transplantation as a single low-resolution HLA mismatch, AMERICAN JOURNAL OF HEMATOLOGY, 90(7), 618-623, 201507
  141. Isolation of mesenchymal stromal/stem cells from small-volume umbilical cord blood units that do not qualify for the banking system, INTERNATIONAL JOURNAL OF HEMATOLOGY, 102(2), 218-229, 201508
  142. Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy, JOURNAL OF HEMATOLOGY & ONCOLOGY, 8, 20150904
  143. Treatment of hepatic amyloid light-chain amyloidosis with bortezomib and dexamethasone in a liver transplant patient, HEPATOLOGY RESEARCH, 45(10), E150-E155, 201510
  144. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic C, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 21(11), 2008-2016, 201511
  145. The Impact of HLA Mismatch Only in the Host-Versus-Graft Direction on the Outcome of Related Hematopoietic Stem Cell Transplantation for Patients with HLA-Homozygous Haplotypes: A Retrospective Analysis of the JSHCT HLA Working Group Study, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 21(2), S159-S160, 2015
  146. A single high-resolution HLA mismatch has a similar adverse impact on the outcome of related hematopoietic stem cell transplantation as a single low-resolution HLA mismatch., A single high-resolution HLA mismatch has a similar adverse impact on the outcome of related hematopoietic stem cell transplantation as a single low-resolution HLA mismatch., 90(7), 2015
  147. Basic understanding of the HLA system in allogeneic hematopoietic cell transplantation, 56(10), 2134-2143, 201510
  148. Early osteoinductive human bone marrow mesenchymal stromal/stem cells support an enhanced hematopoietic cell expansion with altered chemotaxis- and adhesion-related gene expression profiles, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 469(4), 823-829, 20160122
  149. Early application of related SCT might improve clinical outcome in adult T-cell leukemia/lymphoma, BONE MARROW TRANSPLANTATION, 51(2), 205-211, 201602
  150. Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes, BONE MARROW TRANSPLANTATION, 51(3), 403-409, 201603
  151. A multicenter phase 2 study of pomalidomide plus dexamethasone in patients with relapsed and refractory multiple myeloma: the Japanese MM-011 trial, EXPERIMENTAL HEMATOLGY & ONCOLOGY, 5, 20160418
  152. Impact of cyclophosphamide dose of conditioning on the outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia from human leukocyte antigen-identical sibling, INTERNATIONAL JOURNAL OF HEMATOLOGY, 103(4), 461-468, 201604
  153. Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 22(5), 932-940, 201605
  154. Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older, AMERICAN JOURNAL OF HEMATOLOGY, 91(5), E284-E292, 201605
  155. Allogeneic unrelated bone marrow transplantation from older donors results in worse prognosis in recipients with aplastic anemia, HAEMATOLOGICA, 101(5), 644-652, 201605
  156. Maintenance of the functional integrity of mouse hematopoiesis by EED and promotion of leukemogenesis by EED haploinsufficiency, SCIENTIFIC REPORTS, 6, 20160719
  157. Efficacy and safety of rituximab in Japanese patients with acquired thrombotic thrombocytopenic purpura refractory to conventional therapy, INTERNATIONAL JOURNAL OF HEMATOLOGY, 104(2), 228-235, 201608
  158. Tandem autologous versus autologous/allogeneic transplantation for multiple myeloma: propensity score analysis, LEUKEMIA & LYMPHOMA, 57(9), 2077-2083, 201609
  159. Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups, HAEMATOLOGICA, 101(12), 1592-1602, 20161130
  160. Haploidentical and Matched Sibling Donor Hematopoietic Cell Transplantation for Patients with HLA-Homozygous Haplotypes, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 22(11), 2031-2037, 201611
  161. Allogeneic Hematopoietic Cell Transplantation for Leukemic Transformation Preceded by Philadelphia Chromosome Negative Myeloproliferative Neoplasms: A Nationwide Survey by the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 22(12), 2208-2213, 201612
  162. All-trans retinoic acid enhances cytotoxic effect of T cells with an anti-CD38 chimeric antigen receptor in acute myeloid leukemia, CLINICAL & TRANSLATIONAL IMMUNOLOGY, 5, 201612
  163. ★, Biological implications of somatic DDX41 p.625H mutation in acute myeloid leukemia, EXPERIMENTAL HEMATOLOGY, 44(8), 745-754, 2016
  164. Famotidine-induced reactive plasmacytosis and generalized lymphadenopathy: a case report and review of the literature, INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 9(7), 7680-7685, 2016
  165. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Myelodysplastic Syndrome Harboring Trisomy 8, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 23(1), 75-80, 201701
  166. Role of reduced-intensity conditioning allogeneic hematopoietic cell transplantation in older patients with de novo acute myeloid leukemia, ANNALS OF HEMATOLOGY, 96(2), 289-297, 201702
  167. Impact of Human Leukocyte Antigen Allele Mismatch in Unrelated Bone Marrow Transplantation with Reduced-Intensity Conditioning Regimen, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 23(2), 300-309, 201702
  168. Impact of total body irradiation on successful neutrophil engraftment in unrelated bone marrow or cord blood transplantation, AMERICAN JOURNAL OF HEMATOLOGY, 92(2), 171-178, 201702
  169. Low-dose thymoglobulin as second-line treatment for steroid-resistant acute GvHD: an analysis of the JSHCT, BONE MARROW TRANSPLANTATION, 52(2), 252-257, 201702
  170. Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia harboring trisomy 8, ANNALS OF HEMATOLOGY, 96(3), 469-478, 201703
  171. Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation, LEUKEMIA, 31(3), 663-668, 201703
  172. Outcome differences between children and adolescents and young adults with non-Hodgkin lymphoma following stem cell transplantation, INTERNATIONAL JOURNAL OF HEMATOLOGY, 105(3), 369-376, 201703
  173. Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetil, BONE MARROW TRANSPLANTATION, 52(3), 423-430, 201703
  174. A phase I/II trial of intrabone marrow cord blood transplantation and comparison of the hematological recovery with the Japanese nationwide database, BONE MARROW TRANSPLANTATION, 52(4), 574-579, 201704
  175. Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells, INTERNATIONAL JOURNAL OF HEMATOLOGY, 105(5), 587-597, 201705
  176. ★, Highly functional T-cell receptor repertoires are abundant in stem memory T cells and highly shared among individuals, SCIENTIFIC REPORTS, 7, 20170616
  177. Allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia who had central nervous system involvement: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation, INTERNATIONAL JOURNAL OF HEMATOLOGY, 105(6), 805-811, 201706
  178. Tumor growth limited to subcutaneous site vs tumor growth in pulmonary site exhibit differential effects on systemic immunities, ONCOLOGY REPORTS, 38(1), 449-455, 201707
  179. Outcomes of Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients with Abnormalities of the Short Arm of Chromosome 17, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 23(8), 1398-1404, 201708
  180. Clinical impact of pretransplant use of multiple tyrosine kinase inhibitors on the outcome of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia, AMERICAN JOURNAL OF HEMATOLOGY, 92(9), 902-908, 201709
  181. GvHD prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adults with acute leukemia, BONE MARROW TRANSPLANTATION, 52(9), 1261-1267, 201709
  182. Impact of the presence of HLA 1-locus mismatch and the use of low-dose antithymocyte globulin in unrelated bone marrow transplantation, BONE MARROW TRANSPLANTATION, 52(10), 1390-1398, 201710
  183. Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation, BONE MARROW TRANSPLANTATION, 52(11), 1563-1570, 201711
  184. Comparison of Conditioning with Fludarabine/Busulfan and Fludarabine/Melphalan in Allogeneic Transplantation Recipients 50 Years or Older, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 23(12), 2079-2087, 201712
  185. Autologous hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission: outcomes before and after the introduction of arsenic trioxide, LEUKEMIA & LYMPHOMA, 58(5), 1061-1067, 2017
  186. Pharmacological targeting of bone marrow mesenchymal stromal/stem cells for the treatment of hematological disorders, INFLAMMATION AND REGENERATION, 37, 2017
  187. Isolation of mesenchymal stromal/stem cells from cryopreserved umbilical cord blood cells, JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 57(1), 1-8, 2017
  188. Effects of acute exposure to low-dose radiation on the characteristics of human bone marrow mesenchymal stromal/stem cells, INFLAMMATION AND REGENERATION, 37, 2017
  189. ★, Graft-Versus-Host Disease Amelioration by Human Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Is Associated with Peripheral Preservation of Naive T Cell Populations, STEM CELLS, 36(3), 434-445, 201803
  190. Myeloma Cells Are Activated in Bone Marrow Microenvironment by the CD180/MD-1 Complex, Which Senses Lipopolysaccharide, CANCER RESEARCH, 78(7), 1766-1778, 20180401
  191. Safety and efficacy of daratumumab in combination with bortezomib and dexamethasone in Japanese patients with relapsed or refractory multiple myeloma, INTERNATIONAL JOURNAL OF HEMATOLOGY, 107(4), 460-467, 201804
  192. ★, Next-Generation Immune Repertoire Sequencing as a Clue to Elucidate the Landscape of Immune Modulation by Host-Gut Microbiome Interactions, FRONTIERS IN IMMUNOLOGY, 9, 20180403
  193. Impact of a Low CD34(+) Cell Dose on Allogeneic Peripheral Blood Stem Cell Transplantation, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 24(4), 708-716, 201804
  194. Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 24(4), 717-725, 201804
  195. Risk Assessment in Adult T Cell Leukemia/Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 24(4), 832-839, 201804
  196. Prognostic Impact of Donor Source on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in Adults with Chronic Myelomonocytic Leukemia: A Nationwide Retrospective Analysis in Japan, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 24(4), 840-848, 201804
  197. Efficacy and Long-Term Outcomes of Autologous Stem Cell Transplantation in POEMS Syndrome: A Nationwide Survey in Japan, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 24(6), 1180-1186, 201806
  198. Allogeneic haematopoietic cell transplantation for adult acute myeloid leukaemia in second remission: a retrospective study of the Adult Acute Myeloid Leukaemia Working Group of the Japan Society for Haematopoietic Cell Transplantation (JSHCT), BRITISH JOURNAL OF HAEMATOLOGY, 182(2), 245-250, 201807
  199. Outcomes of patients who developed subsequent solid cancer after hematopoietic cell transplantation, BLOOD ADVANCES, 2(15), 1901-1913, 20180814
  200. Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory mantle cell lymphoma, ANNALS OF HEMATOLOGY, 97(8), 1445-1452, 201808
  201. Impact of HIV Infection on Transplant Outcomes after Autologous Peripheral Blood Stem Cell Transplantation: A Retrospective Study of Japanese Registry Data, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 24(8), 1596-1601, 201808
  202. Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report, CLINICAL NEPHROLOGY, 90(3), 232-236, 201809
  203. Safety and Efficacy of Once-Daily Intravenous Busulfan in Allogeneic Transplantation: A Matched-Pair Analysis, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 24(10), 2139-2144, 201810
  204. Allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia with 11q23 abnormality: a retrospective study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT), ANNALS OF HEMATOLOGY, 97(11), 2173-2183, 201811
  205. Suppression effect on IFN-gamma of adipose tissue-derived mesenchymal stem cells isolated from beta 2-microglobulin-deficient mice, EXPERIMENTAL AND THERAPEUTIC MEDICINE, 16(5), 4277-4282, 201811
  206. Allogeneic hematopoietic stem cell transplantation for the treatment of BCR-ABL1-negative atypical chronic myeloid leukemia and chronic neutrophil leukemia: A retrospective nationwide study in Japan, LEUKEMIA RESEARCH, 75, 50-57, 201812
  207. Impacts of thymoglobulin in patients with acute leukemia in remission undergoing allogeneic HSCT from different donors, BLOOD ADVANCES, 3(2), 105-115, 20190122
  208. High probability of follow-up termination among AYA survivors after allogeneic hematopoietic cell transplantation, BLOOD ADVANCES, 3(3), 397-405, 20190212
  209. The outcome and characteristics of patients with relapsed adult T cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation, HEMATOLOGICAL ONCOLOGY, 37(1), 54-61, 201902
  210. Comparison of HLA Allele Mismatch and Antigen Mismatch in Unrelated Bone Marrow Transplantation in Patients with Leukemia, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 25(3), 436-442, 201903
  211. Clinical Implications of t(11;14) in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 25(3), 474-479, 201903
  212. Patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: trends in survival during the past two decades, BONE MARROW TRANSPLANTATION, 54(4), 578-586, 201904
  213. HLA discrepancy between graft and host rather than that graft and first donor impact the second transplant outcome, HAEMATOLOGICA, 104(5), 1055-1061, 20190430
  214. Hematopoietic stem cell transplantation in children and adolescents with relapsed or refractory B-cell non-Hodgkin lymphoma, INTERNATIONAL JOURNAL OF HEMATOLOGY, 109(4), 483-490, 201904
  215. Prognostic impact of melphalan dose and total body irradiation use in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation with reduced-intensity conditioning, LEUKEMIA & LYMPHOMA, 60(6), 1493-1502, 20190512
  216. Cellular responses to ionizing radiation change quickly over time during early development in zebrafish, CELL BIOLOGY INTERNATIONAL, 43(5), 516-527, 201905
  217. High-Dose Chemotherapy with Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma: Data From the Japan Society for Hematopoietic Cell Transplantation Registry, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 25(5), 899-905, 201905
  218. Increased opportunity for prolonged survival after allogeneic hematopoietic stem cell transplantation in patients aged 60-69years with myelodysplastic syndrome, ANNALS OF HEMATOLOGY, 98(6), 1367-1381, 201906
  219. Short-term clinical outcomes after HLA 1-locus mismatched uPBSCT are similar to that after HLA-matched uPBSCT and uBMT, INTERNATIONAL JOURNAL OF HEMATOLOGY, 109(6), 684-693, 201906
  220. BM is preferred over PBSCs in transplantation from an HLA-matched related female donor to a male recipient, BLOOD ADVANCES, 3(11), 1750-1760, 20190611
  221. Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with hepatitis-associated aplastic anemia, INTERNATIONAL JOURNAL OF HEMATOLOGY, 109(6), 711-717, 201906
  222. Outcomes of second allogeneic haematopoietic stem cell transplantation in patients with relapse of myelodysplastic syndrome, BRITISH JOURNAL OF HAEMATOLOGY, 186(1), 86-90, 201907
  223. Effects of HLA mismatch on cytomegalovirus reactivation in cord blood transplantation, BONE MARROW TRANSPLANTATION, 54(7), 1004-1012, 201907
  224. Risk Factors and Predictive Scoring System For Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 25(7), 1441-1449, 201907
  225. Clinical impact of the loss of chromosome 7q on outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem cell transplantation, BONE MARROW TRANSPLANTATION, 54(9), 1471-1481, 201909
  226. Allogeneic hematopoietic cell transplantation for patients with a history of multiple relapses of acute myeloid leukemia, ANNALS OF HEMATOLOGY, 98(9), 2179-2186, 201909
  227. Effect of allogeneic hematopoietic cell transplantation for patients with T-prolymphocytic leukemia: a retrospective study from the Adult Lymphoma Working Group of the Japan Society for hematopoietic cell transplantation, ANNALS OF HEMATOLOGY, 98(9), 2213-2220, 201909
  228. Risk Stratification and Prognosticators of Acute Myeloid Leukemia with Myelodysplasia-Related Changes in Patients Undergoing Allogeneic Stem Cell Transplantation: A Retrospective Study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 25(9), 1730-1743, 201909
  229. Efficacy and safety of autologous stem cell transplantation in patients aged >= 65 years with multiple myeloma in the era of novel agents, BONE MARROW TRANSPLANTATION, 54(10), 1595-1604, 201910
  230. ABO blood type incompatibility lost the unfavorable impact on outcome in unrelated bone marrow transplantation, BONE MARROW TRANSPLANTATION, 54(10), 1676-1685, 201910
  231. Tyrosine kinase inhibitor prophylaxis after transplant for Philadelphia chromosome-positive acute lymphoblastic leukemia, CANCER SCIENCE, 110(10), 3255-3266, 201910
  232. Using a machine learning algorithm to predict acute graft-versus-host disease following allogeneic transplantation, BLOOD ADVANCES, 3(22), 3626-3634, 20191126
  233. Role of alternative donor allogeneic hematopoietic stem cell transplantation in patients with intermediate- or poor-risk acute myeloid leukemia in first complete remission, BONE MARROW TRANSPLANTATION, 54(12), 2004-2012, 201912
  234. Comparison between autologous and allogeneic stem cell transplantation as salvage therapy for multiple myeloma relapsing/progressing after autologous stem cell transplantation, HEMATOLOGICAL ONCOLOGY, 37(5), 586-594, 201912
  235. Impact of High-Frequency HLA Haplotypes on Clinical Cytomegalovirus Reactivation in Allogeneic Hematopoietic Stem Cell Transplantation, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 25(12), 2482-2489, 201912
  236. Successful Treatment of Acute Chest Syndrome with Manual Exchange Transfusion in a Patient with Sickle Beta(+)-thalassemia, INTERNAL MEDICINE, 58(11), 1629-1634, 2019
  237. Impact of Homozygous Conserved Extended HLA Haplotype on Single Cord Blood Transplantation: Lessons for Induced Pluripotent Stem Cell Banking and Transplantation in Allogeneic Settings, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 26(1), 132-138, 202001
  238. Autologous hematopoietic cell transplantation for acute myeloid leukemia in adults: 25 years of experience in Japan, INTERNATIONAL JOURNAL OF HEMATOLOGY, 111(1), 93-102, 202001
  239. Prognostic factors for adult single cord blood transplantation among European and Japanese populations: the Eurocord/ALWP-EBMT and JSHCT/JDCHCT collaborative study, LEUKEMIA, 34(1), 128-137, 202001
  240. Assessment of early treatment response on MRI in multiple myeloma: Comparative study of whole-body diffusion-weighted and lumbar spinal MRI, PLOS ONE, 15(2), 20200227
  241. Increased Relapse Risk of Acute Lymphoid Leukemia in Homozygous HLA-C1 Patients after HLA-Matched Allogeneic Transplantation: A Japanese National Registry Study, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 26(3), 431-437, 202003
  242. Mixed Chimerism and Secondary Graft Failure in Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 26(3), 445-450, 202003
  243. Conditioning Intensity for Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients with Poor-Prognosis Cytogenetics in First Complete Remission, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 26(3), 463-471, 202003
  244. Effects of Haplotype Matching on Outcomes after Adult Single-Cord Blood Transplantation, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 26(3), 509-518, 202003
  245. Impact of HLA Allele Mismatch at HLA-A, -B, -C, and-DRB1 in Single Cord Blood Transplantation, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 26(3), 519-528, 202003
  246. Impact of pretransplant donor-specific anti-HLA antibodies on cord blood transplantation on behalf of the Transplant Complications Working Group of Japan Society for Hematopoietic Cell Transplantation, BONE MARROW TRANSPLANTATION, 55(4), 722-728, 202004
  247. Low incidence of posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation in patients with lymphoma treated with rituximab, HEMATOLOGICAL ONCOLOGY, 38(2), 146-152, 202004
  248. Kdm6a Deficiency Activates Inflammatory Pathways, Promotes M2 Macrophage Polarization, and Causes Bladder Cancer in Cooperation with p53 Dysfunction, CLINICAL CANCER RESEARCH, 26(8), 2065-2079, 202004
  249. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for ATL with HTLV-1 Antibody-Positive Donors, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 26(4), 718-722, 202004
  250. Could the minimum number of haematopoietic stem cells to obtain engraftment exist in unrelated, single cord blood transplantation?, Br J Haematol, 189(2), e56-e60, 202004
  251. Influence of HLA 1-3-locus mismatch and antithymocyte globulin administration in unrelated bone marrow transplantation, ANNALS OF HEMATOLOGY, 99(5), 1099-1110, 202005
  252. Molecular genetic analysis of inherited protein C deficiency caused by the novel large deletion across two exons of PROC., Thromb Res., 188, 115-118, 202005
  253. Immune dysregulation syndrome with de novo CTLA4 germline mutation responsive to abatacept therapy, INTERNATIONAL JOURNAL OF HEMATOLOGY, 111(6), 897-902, 202006
  254. Immune dysregulation syndrome with de novo CTLA4 germline mutation responsive to abatacept therapy., Int J Hematol, 111(6), 897-902, 202006
  255. Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia conducted in Japan during the past quarter century, ANNALS OF HEMATOLOGY, 99(6), 1351-1360, 202006
  256. Pomalidomide-associated progressive multifocal leukoencephalopathy in multiple myeloma: cortical susceptibility-weighted imaging hypointense findings prior to clinical deterioration, JOURNAL OF NEUROVIROLOGY, 26(3), 452-455, 202006
  257. ★, Stage-Specific Effects of Ionizing Radiation during Early Development, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 21(11), 202006
  258. Clinical course of autologous recovery with chromosomal abnormalities after allogeneic hematopoietic stem cell transplantation, Bone Marrow Transplant, 55(6), 1023-1028, 202006
  259. Clinical course of autologous recovery with chromosomal abnormalities after allogeneic hematopoietic stem cell transplantation., Bone Marrow Transplant, 55(6), 1023-1028, 202006
  260. Allogeneic hematopoietic stem cell transplantation for adult patients with B-cell acute lymphoblastic leukemia harboring t(1;19)(q23;p13.3); comparison with normal karyotype, BONE MARROW TRANSPLANTATION, 55(7), 1337-1346, 202007
  261. Outcome of stem cell transplantation for Waldenstrom's macroglobulinemia: analysis of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Lymphoma Working Group, ANNALS OF HEMATOLOGY, 99(7), 1635-1642, 202007
  262. Impact of graft-versus-host disease and graft-versus-leukemia effect based on minimal residual disease in Philadelphia chromosome-positive acute lymphoblastic leukemia, BRITISH JOURNAL OF HAEMATOLOGY, 190(1), 84-92, 202007
  263. Outcome and Risk Factors for Therapy-Related Myeloid Neoplasms Treated with Allogeneic Stem Cell Transplantation in Japan, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 26(8), 1543-1551, 202008
  264. A high CD34(+) cell dose is associated with better disease-free survival in patients with low-risk diseases undergoing peripheral blood stem cell transplantation from HLA-matched related donors, BONE MARROW TRANSPLANTATION, 55(9), 1726-1735, 202009
  265. Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelodysplastic/Myeloproliferative Neoplasms-Unclassifiable: A Retrospective Nationwide Study of the Japan Society for Hematopoietic Cell Transplantation, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 26(9), 1607-1611, 202009
  266. The impacts of BCR-ABL1mutations in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation, ANNALS OF HEMATOLOGY, 99(10), 2393-2404, 202010
  267. Long-term results of reduced-intensity conditioning allogeneic hematopoietic cell transplantation for older patients with acute myeloid leukemia: a retrospective analysis of 10-year follow-up data, BONE MARROW TRANSPLANTATION, 55(10), 2008-2016, 202010
  268. Updated Comparison of 7/8 HLA Allele-Matched Unrelated Bone Marrow Transplantation and Single-Unit Umbilical Cord Blood Transplantation as Alternative Donors in Adults with Acute Leukemia, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 26(11), 2105-2114, 202011
  269. Effects of Acute and Chronic Graft-versus-myelodysplastic Syndrome on Long-term Outcomes Following Allogeneic Hematopoietic Cell Transplantation, CLINICAL CANCER RESEARCH, 26(24), 6483-6493, 20201215
  270. Use of unapproved or off-label drugs in Japan for the treatment of graft-versus-host disease and post-transplant viral infection, INTERNATIONAL JOURNAL OF HEMATOLOGY, 112(6), 841-850, 202012
  271. Allogeneic Hematopoietic Stem Cell Transplantation for Post-essential Thrombocythemia and Post-polycythemia Vera Myelofibrosis, INTERNAL MEDICINE, 59(16), 1947-1956, 2020
  272. Streptococcus gallolyticus ssp. pasteurianus bacteremia during chemotherapy induced neutropenia in a patient with malignant lymphoma., Hiroshima Journal of Medical Science, 69(2), 47-50, 2020
  273. ★, Allogeneic hematopoietic cell transplantation using fludarabine plus myeloablative busulfan and melphalan confers promising survival in high-risk hematopoietic neoplasms: a single-center retrospective analysis, HEMATOLOGY, 26(1), 186-198, 20210101
  274. Chromosomal defects and survival in patients with adult T-cell leukemia/lymphoma after allogeneic HSCT, BLOOD ADVANCES, 5(2), 475-486, 20210126
  275. Cyclosporine/methotrexate versus tacrolimus/methotrexate with or without anti-thymocyte globulin as GVHD prophylaxis in adult patients with aplastic anemia, ANNALS OF HEMATOLOGY, 100(1), 217-228, 202101
  276. GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma, BONE MARROW TRANSPLANTATION, 56(1), 155-166, 202101
  277. Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with paroxysmal nocturnal hemoglobinuria, INTERNATIONAL JOURNAL OF HEMATOLOGY, 113(1), 122-127, 202101
  278. UTX maintains the functional integrity of the murine hematopoietic system by globally regulating aging-associated genes, BLOOD, 137(7), 908-922, 20210218
  279. Comparison of immunosuppressant regimens in salvage cord blood transplantation for graft failure after allogeneic hematopoietic stem cell transplantation, BONE MARROW TRANSPLANTATION, 56(2), 400-410, 202102
  280. Hematopoietic stem cell transplantation for diffuse large B-cell lymphoma having 8q24/MYCrearrangement in Japan, HEMATOLOGICAL ONCOLOGY, 39(1), 66-74, 202102
  281. Impact of event-free survival status after stem cell transplantation on subsequent survival of patients with lymphoma, BLOOD ADVANCES, 5(5), 1412-1424, 20210309
  282. ★, Characterization of novel zebrafish MHC class I U lineage genes and their haplotype, DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 116, 202103
  283. Individual HLAs influence immunological events in allogeneic stem cell transplantation from HLA-identical sibling donors, BONE MARROW TRANSPLANTATION, 56(3), 646-654, 202103
  284. Allogeneic Hematopoietic Cell Transplantation for Adolescent and Young Adult Patients with Acute Myeloid Leukemia, TRANSPLANTATION AND CELLULAR THERAPY, 27(4), 202104
  285. Single Cord Blood Transplantation Versus Unmanipulated Haploidentical Transplantation for Adults with Acute Myeloid Leukemia in Complete Remission, TRANSPLANTATION AND CELLULAR THERAPY, 27(4), 202104
  286. Impact of 2 Gy gamma-irradiation on the hallmark characteristics of human bone marrow-derived MSCs, INTERNATIONAL JOURNAL OF HEMATOLOGY, 113(5), 703-711, 202105
  287. Relapse of acute myeloid leukemia after allogeneic hematopoietic cell transplantation: clinical features and outcomes, BONE MARROW TRANSPLANTATION, 56(5), 1126-1133, 202105
  288. Effect of methotrexate dose in graft-versus-host disease prophylaxis after single-unit cord blood transplantation in adult acute myeloid leukemia, INTERNATIONAL JOURNAL OF HEMATOLOGY, 113(6), 840-850, 202106
  289. Reduced leukemia relapse through cytomegalovirus reactivation in killer cell immunoglobulin-like receptor-ligand-mismatched cord blood transplantation, BONE MARROW TRANSPLANTATION, 56(6), 1352-1363, 202106
  290. Single cord blood transplantation for acute myeloid leukemia patients aged 60 years or older: a retrospective study in Japan, ANNALS OF HEMATOLOGY, 100(7), 1849-1861, 202107
  291. Personalized prediction of overall survival in patients with AML in non-complete remission undergoing allo-HCT, CANCER MEDICINE, 10(13), 4250-4268, 202107
  292. Adding melphalan to fludarabine and a myeloablative dose of busulfan improved survival after allogeneic hematopoietic stem cell transplantation in a propensity score-matched cohort of hematological malignancies, BONE MARROW TRANSPLANTATION, 56(7), 1691-1699, 202107
  293. Residual disease is a strong prognostic marker in patients with acute lymphoblastic leukaemia with chemotherapy-refractory or relapsed disease prior to allogeneic stem cell transplantation, BRITISH JOURNAL OF HAEMATOLOGY, 194(2), 403-413, 202107
  294. Single response assessment of transplant-ineligible multiple myeloma: a supplementary analysis of JCOG1105 (JCOG1105S1), JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 51(7), 1059-1066, 202107
  295. Does one model fit all? Predicting non-relapse mortality after allogeneic hematopoietic cell transplantation., Bone Marrow Transplant, 56(7), 1720-1722, 202107
  296. Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm., Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm., 125(23), 2015
  297. NUDT15 polymorphism influences the metabolism and therapeutic effects of acyclovir and ganciclovir, NATURE COMMUNICATIONS, 12(1), 20210707
  298. Erdheim-Chester Disease With Left Atrial Pseudotumor Involvement., Circ J., 85(6), 957, 20210525
  299. Comparison of fludarabine, a myeloablative dose of busulfan, and melphalan vs conventional myeloablative conditioning regimen in patients with relapse and refractory acute myeloid leukemia in non-remission status., Bone Marrow Transplant, 56(9), 2302-2304, 202109
  300. Low-dose antithymocyte globulin inhibits chronic graft-versus-host disease in peripheral blood stem cell transplantation from unrelated donors, BONE MARROW TRANSPLANTATION, 56(9), 2231-2240, 202109
  301. Syngeneic hematopoietic stem cell transplantation for acute myeloid leukemia: a propensity score-matched analysis, BLOOD CANCER JOURNAL, 11(9), 20210924
  302. Off-the-shelf bone marrow-derived mesenchymal stem cell treatment for acute graft-versus-host disease: real-world evidence, BONE MARROW TRANSPLANTATION, 56(10), 2355-2366, 202110
  303. Impact of the combination of donor age and HLA disparity on the outcomes of unrelated bone marrow transplantation, BONE MARROW TRANSPLANTATION, 56(10), 2410-2422, 202110
  304. Optimal treatment for Philadelphia-negative acute lymphoblastic leukemia in first remission in the era of high-intensity chemotherapy, INTERNATIONAL JOURNAL OF HEMATOLOGY, 114(5), 608-619, 202111
  305. Autophagic degradation of NOXA underlies stromal cell-mediated resistance to proteasome inhibitors in mantle cell lymphoma, LEUKEMIA RESEARCH, 111, 202112
  306. Prognostic value of measurable residual disease at allogeneic transplantation for adults with core binding factor acute myeloid leukemia in complete remission, BONE MARROW TRANSPLANTATION, 56(11), 2779-2787, 202111
  307. Peritransplant glucocorticoids redistribute donor T cells to the bone marrow and prevent relapse after haploidentical SCT, JCI INSIGHT, 6(22), 20211122
  308. Impact of HLA disparity on the risk of overall mortality in patients with grade II-IV acute GVHD on behalf of the HLA Working Group of Japan Society for Hematopoietic Cell Transplantation, BONE MARROW TRANSPLANTATION, 56(12), 2990-2996, 202112
  309. Sudden hearing loss in a young patient with chronic myelogenous leukemia., Hiroshima J Med Sci., 70, 39-42, 202112
  310. Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine, CANCER SCIENCE, 112(12), 5034-5045, 202112
  311. Difference in outcomes following allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndromes, LEUKEMIA & LYMPHOMA, 62(14), 3411-3419, 20211206
  312. Allogeneic Hematopoietic Cell Transplantation from Alternative Donors in Acute Myelogenous Leukemia: A Comparative Analysis, TRANSPLANTATION AND CELLULAR THERAPY, 27(12), 202112
  313. Graft-Versus-Host Disease Prophylaxis Using Low-Dose Antithymocyte Globulin in Peripheral Blood Stem Cell Transplantation-A Matched-Pair Analysis, TRANSPLANTATION AND CELLULAR THERAPY, 27(12), 202112
  314. Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia, BLOOD ADVANCES, 6(1), 238-247, 20220111
  315. Total body irradiation-containing conditioning regimens without antithymocyte globulin in adults with aplastic anemia undergoing umbilical cord blood transplantation, ANNALS OF HEMATOLOGY, 101(1), 165-175, 202201
  316. Cooccurrence of CD10-Positive and CD10-Negative Mantle Cell Lymphoma Complicated With Central Nervous System Involvement Solely by CD10-Positive Population, CUREUS JOURNAL OF MEDICAL SCIENCE, 14(1), 20220117
  317. The impact of GVHD on outcomes after adult single cord blood transplantation in European and Japanese populations, BONE MARROW TRANSPLANTATION, 57(1), 57-64, 202201
  318. Periodontal inflamed surface area in oral cavity associated with febrile neutropenia in patients with hematologic malignancy undergoing chemotherapy, SCIENTIFIC REPORTS, 12(1), 20220215
  319. Impact of donor types on reduced-intensity conditioning allogeneic stem cell transplant for mature lymphoid malignancies, BONE MARROW TRANSPLANTATION, 57(2), 243-251, 202202
  320. Retrospective Analysis of Autologous Stem Cell Transplantation for AL Amyloidosis: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell Transplantation, TRANSPLANTATION AND CELLULAR THERAPY, 28(2), 76-82, 202202
  321. Long-term follow-up of patients with ATL after autologous stem cell transplantation., Bone Marrow Transplant, 57(2), 323-325, 202202
  322. HLA 1-3 antigen-mismatched related peripheral blood stem cells transplantation using low-dose antithymocyte globulin versus unrelated cord blood transplantation, AMERICAN JOURNAL OF HEMATOLOGY, 97(3), 311-321, 20220301
  323. Impact of HLA Epitope Matching on Outcomes After Unrelated Bone Marrow Transplantation, FRONTIERS IN IMMUNOLOGY, 13, 20220303
  324. Human leukocyte antigen (HLA) haplotype matching in unrelated single HLA allele mismatch bone marrow transplantation, BONE MARROW TRANSPLANTATION, 57(3), 407-415, 202203
  325. Donor lymphocyte infusion after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia, ANNALS OF HEMATOLOGY, 101(3), 643-653, 202203
  326. Decision Analysis for Unrelated Bone Marrow Transplantation or Immediate Cord Blood Transplantation for Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Remission, TRANSPLANTATION AND CELLULAR THERAPY, 28(3), 202203
  327. Essential Roles of the Transcription Factor NR4A1 in Regulatory T Cell Differentiation under the Influence of Immunosuppressants, JOURNAL OF IMMUNOLOGY, 208(9), 2122-2130, 20220501
  328. Improved trends in survival and engraftment after single cord blood transplantation for adult acute myeloid leukemia, BLOOD CANCER JOURNAL, 12(5), 20220525
  329. Autologous or allogeneic hematopoietic cell transplantation for relapsed or refractory PTCL-NOS or AITL, LEUKEMIA, 36(5), 1361-1370, 202205
  330. Case of non-secretory multiple myeloma eventually diagnosed by F-18-FDG PET/CT, CLINICAL CASE REPORTS, 10(6), 202206
  331. Improved outcomes of single-unit cord blood transplantation for acute myeloid leukemia by killer immunoglobulin-like receptor 2DL1-ligand mismatch, BONE MARROW TRANSPLANTATION, 57(7), 1171-1179, 202207
  332. Prognostic Factors for Outcomes of Allogeneic HSCT for Children and Adolescents/Young Adults With CML in the TKI Era, TRANSPLANTATION AND CELLULAR THERAPY, 28(7), 376-389, 202207
  333. Primary Pulmonary Mucosa-associated Lymphoid Tissue Lymphoma with the High Expression of IgG4, INTERNAL MEDICINE, 61(7), 1043-1048, 2022

Invited Lecture, Oral Presentation, Poster Presentation

  1. Recent advancement in stem cell transplantation for casualties of nuclear disaster., Tatsuo Ichinohe, 15th International Congress of Radiation Research, 2015/05/27, With Invitation, English
  2. Analysis of radiation-induced responses during early embryonic development of zebrafish., Honjo Y, Kamiya K, Ichinohe T., 15th International Congress of Radiation Research, 2015/05/27, Without Invitation, Japanese
  3. Total-body Irradiation Is Widely Heterogenous Depending on the Anatomical Site., Kumi Oshima, Masahiro Kenjo, Yasushi Nagata, Tatsuo Ichinohe., 20th Annual Congress of Asia-Pacific Blood and Marrow Transplantation Group, 2015/11/01, Without Invitation, Japanese
  4. Comprehensive T-Cell Receptor Repertoire Analysis Using Deep Sequencing and Single Cell Cloning Reveals Extreme Oligoclonality of Ex Vivo Expanded Cytomegalovirus-Reactive Cytotoxic T-Cells., Takahiko Miyama, Takakazu Kawase, Kazutaka Kitaura, Ren Chishaki, Masashi Shibata, Kumi Oshima, Hiroshi Hamana, Hiroyuki Kishi, Kiyotaka Kuzushima, Hiroh Saji, Ryuji Suzuki, Tatsuo Ichinohe., 57th Annual Meeting of the American Society of Hematology, 2015/12/05, Without Invitation, English
  5. Vitamin K2 Supports Hematopoiesis through Acting on Bone Marrow Mesenchymal Stromal/Stem Cells, Aya Fujishiro, Yasuo Miura, Masaki Iwasa, Sumie Fujii, Akihiro Tamura, Atsushi Sato, Asumi Yokota, Noriko Sugino, Hideyo Hirai, Akira Ando, Tatsuo Ichinohe, Taira Maekawa., 57th Annual Meeting of the American Society of Hematology, 2015/12/05, Without Invitation, English
  6. Impact of Unbalanced Translocation Der(1;7)(q10;p10) and -7/Del(7q) on the Prognostic Value after Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndromes: A Nationwide Retrospective Study., Hidehiro Itonaga, Kazunari Aoki, Jun Aoki, Ken Ishiyama, Takayuki Ishikawa, Kazuteru Ohashi, Takahiro Fukuda, Yukiyasu Ozawa, Naoki Kobayashi, Naoyuki Uchida, Tetsuya Eto, Minoko Takanashi, Tatsuo Ichinohe, Yoshiko Atsuta, Yasushi Miyazaki., 57th Annual Meeting of the American Society of Hematology, 2015/12/06, Without Invitation, English
  7. All-Trans Retinoic Acid and Interferon-Alpha Increase CD38 Expression on Adult T-Cell Leukemia Cells and Sensitize Them to T Cells Bearing Anti-CD38 Chimeric Antigen Receptors., Keichiro Mihara, Tetsumi Yoshida, Seiko Ishida, Yoshifumi Takei, Akira Kitanaka, Kazuya Shimoda, Kazuhiro Morishita, Yoshihiro Takihara, Tatsuo Ichinohe., 57th Annual Meeting of the American Society of Hematology, 2015/12/07, Without Invitation, English
  8. Bortezomib Attenuates Adhesion of B Cell Precursor Acture Lymphoblastic Lleukemia Cells to Bone Marrow Mesenchymal Stromal/Stem Cells Via Regulating SPARC Expression., Masaki Iwasa, Yasuo Miura, Aya Fujishiro, Sumie Fujii, Noriko Sugino, Satoshi Yoshioka, Akihiro Tamura, Atsushi Sato, Asumi Yokota, Katsuyuki Kito, Akira Ando, Hideyo Hirai, Akifumi Takaori-Kondo, Tatsuo Ichinohe, Taira Maekawa., 57th Annual Meeting of the American Society of Hematology, 2015/12/07, Without Invitation, English
  9. Donor Cell-Derived Hematologic Malignancy: A Survey of Complication Working Group of the Japan Society for Hematopoietic Cell Transplantation., Motohiro Kato, Takuya Yamashita, Ritsuro Suzuki, Kimikazu Matsumoto, Hisakazu Nishimori, Satoshi Takahashi, Koji Iwato, Chiaki Nakaseko, Tadakazu Kondo, Kazunori Imada, Fumihiko Kimura, Tatsuo Ichinohe, Yoshiko Hashii, Koji Kato, Yoshiko Atsuta, Shuichi Taniguchi, Takahiro Fukuda., 57th Annual Meeting of the American Society of Hematology, 2015/12/07, Without Invitation, English
  10. Outcome and Risk Factors for Therapy-Related Myeloid Neoplasms Treated with allogeneic Stem Cell Transplantation., Michiko Kida, Kensuke Usuki, Naoyuki Uchida, Takahiro Fukuda, Koji Iwato, Ken-ichi Matsuoka, Tetsuya Eto, Tatsuo Ichinohe, Yoshiko Atsuta, Minoko Takanashi, Akiyoshi Takami, Yasushi Miyazaki, Shingo Yano, Ken Ishiyama., 57th Annual Meeting of the American Society of Hematology, 2015/12/07, Without Invitation, English
  11. Halving time of BCR-ABL1 mRNA calculated by RQ-PCR seems to be a useful tool in CML treatment by TKI., Hideo Tanaka, Kaori Kihara, Jun Imagawa, Tatsuo Ichinohe., The 77th Annual Meeting of the Japanese Society of Hematology, 2015/10/16, Without Invitation, Japanese
  12. Quantitative tracing of T-cell diversity using deep sequencing in a recipient of allogeneic HCT., Kumi Oshima, Kazutaka Kitaura, Takahiko Miyama, Takakazu Kawase, Tomoko Inoue, Seiko Ishida, Kyohei Yamada, Naoya Yamasaki, Tadasuke Awaya, Moe Okuno, Tetsumi Yoshida, Seiji Saito, Yoshiaki Kuroda, Sayaka Sugihara, Jun Imagawa, Shinya Katsutani, Keichiro Mihara, Teruhisa Fujii, Ryuji Suzuki, Tatsuo Ichinohe., The 77th Annual Meeting of the Japanese Society of Hematology, 2015/10/16, Without Invitation, Japanese
  13. Investigator-initiated clinical trial of rituximab for thrombotic thrombocytopenic purpura., Yoshitaka Miyakawa, Kazunori Imada, Tatsuo Ichinohe, Yusuke Yamane, Kenji Nishio, Takayuki Abe, Yoshihiro Fujimura, Masanori Matsumoto, Shinichiro Okamoto., The 77th Annual Meeting of the Japanese Society of Hematology, 2015/10/16, Without Invitation, Japanese
  14. Tandem autologous vs. autologous/allogeneic transplantation for myeloma – Propensity score analysis., Koji Kawamura, Takashi Ikeda, Shotaro Hagiwara, Takehiko Mori, Atsushi Shinagawa, Kaichi Nishiwaki, Kazuteru Ohashi, Shiro Kubonishi, Tatsuo Ichinohe, Koji Kato, Yasuo Morishima, Yoshiko Atsuta, Kazutaka Sunami, Yoshinobu Kanda., The 77th Annual Meeting of the Japanese Society of Hematology, 2015/10/17, Without Invitation, Japanese
  15. Graft-versus-host disease after syngeneic hematopoietic stem cell transplantation., Tetsuya Nishida, Yasushi Onishi, Takeshi Kobayashi, Takehiko Mori, Naoki Shirafuji, Heiwa Kanamori, Yasuhiko Miyazaki, Tatsuo Ichinohe, Yoshiko Atsuta, Makoto Murata., The 77th Annual Meeting of the Japanese Society of Hematology, 2015/10/17, Without Invitation, Japanese
  16. Patterns of immunoglobulin gene rearrangement may predict prognosis of diffuse large B-cell lymphoma., Tetsumi Yoshida, Keichiro Mihara, Tomohiko Taki, Yoshihiro Takihara, Tatsuo Ichinohe., The 77th Annual Meeting of the Japanese Society of Hematology, 2015/10/17, Without Invitation, Japanese
  17. Comprehensive analysis of CMV-specific T-cell repertoire by deep sequencing and single cell cloning., Takahiko Miyama, Takakazu Kawase, Kazutaka Kitaura, Ren Chishaki, Masashi Shibata, Kumi Oshima, Hiroshi Hamana, Hiroyuki Kishi, Kiyotaka Kuzushima, Hiroh Saji, Ryuji Suzuki, Tatsuo Ichinohe., The 77th Annual Meeting of the Japanese Society of Hematology, 2015/10/17, Without Invitation, Japanese
  18. Clinical outcome of allo-HSCT for relapsed ATLL after chemotherapy: the JCHCT ATL-WG study., Hiroshi Fujiwara, Shigeo Fuji, Atsushi Wake, Koji Kato, Yoshifusa Takatsuka, Takahiro Fukuda, Jun Tagichi, Naoyuki Uchida, Toshihiro Miyamoto, Michihiro Hidaka, Yasuhiko Miyazaki, Takeaki Tomoyose, Tokiko Nagamura, Yasuo Moroshima, Tatsuo Ichinohe, Yoshiko Atsuta, Atae Utsunomiya., The 77th Annual Meeting of the Japanese Society of Hematology, 2015/10/17, Without Invitation, Japanese
  19. Donor cell-derived hematologyic malignancy after allogeneic hematopoietic stem cell transplantation., Motohiro Kato, Takuya Yamashita, Ritsuro Suzuki, Kimikazu Matsumoto, Hisakazu Nishimori, Satoshi Takahashi, Koji Iwato, Chiaki Nakaseko, Tatuso Ichinohe, Yoshiko Atsuta, Shuichi Taniguchi, Takahiro Fukuda., The 77th Annual Meeting of the Japanese Society of Hematology, 2015/10/18, Without Invitation, Japanese
  20. The current status of prophylaxis in adult patients with hemophilia: an instituteon observantion study., Seji Saito, Naoya Yamasaki, Teruhisa Fujii, Tatsuo Ichinohe., The 77th Annual Meeting of the Japanese Society of Hematology, 2015/10/17, Without Invitation, Japanese
  21. CBT versus matched sibling BMT or PBSCT in 50 years older; analysis of Donor/Source WG of the JSHCT., Takaaki Konuma, Nabuhiro Tsukada, Junya Kanda, Naoyuki Uchida, Yuju Ohno, Shigesaburo Miyakoshi, Heiwa Kanamori, Michihiro Hidaka, Toru Sakura, Makoto Onizuka, Naoki Kobayashi, Masashi Sawa, Tetsuya Eto, Yoshiko Matsuhashi, Koji Kato, Tatsuo Ichinohe, Yoshiko Atsuta, Koichi Miyamuta., The 77th Annual Meeting of the Japanese Society of Hematology, 2015/10/17, Without Invitation, Japanese
  22. Bacillus cereus infection associated with pneumatosis intestinelis in a patient with acute leukemia., Mai Nishina, Kumi Oshima, Kyohei Yamada, Tadasuke Awaya, Jun Imagawa, Norihumi Shigemoto, Hiroki Ohge, Tatsuo Ichinohe., The 77th Annual Meeting of the Japanese Society of Hematology, 2015/10/17, Without Invitation, Japanese
  23. A survey of ESBL-producing Enterobacteriaceae in a single institute hematology unit., Tomoko Inoue, Kumi Oshima, Norifumi Shigemoto, Hiroki Ohge, Tatsuo Ichinohe., 2015/10/17, Without Invitation, Japanese
  24. Effects of low-dose irradiation on the function of human bone marrow mesenchymal stromal/stem cells., Aya Fujishiro, Yasuo Miura, Masaki Iwasa, Akihiro Tamura, Atsushi Sato, Asumi Yokota, Hideyo Hirai, Akira Ando, Taira Maekawa, Tatsuo Ichinohe., The 77th Annual Meeting of the Japanese Society of Hematology, 2015/10/17, Without Invitation, Japanese
  25. Hematopoietic Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma Harboring a 8q24/ MYC Rearrangement: A Retrospective Registry Study from the Japan Society for Hematopoietic Cell Transplantation., Tsutomu Takahashi, Ritsuro Suzuki, Koji Izutsu, Hideyuki Nakazawa, Sachiko Suzuki, Junya Kuroda, Katsuji Kaida, Hitoshi Ohno, Takahiro Fukuda, Tatsuo Ichinohe, Yoshiko Atsuta, Junji Suzumiya., 58th Annual Meeting of the American Society of Hematology, 2016/12/03, Without Invitation, English
  26. Late Adherent Subpopulation in Umbilical Cord Blood Has the Same Characteristics and Hematopoiesis-Supporting Capacity As Mesenchymal Stromal/Stem Cells., Satoshi Yoshioka, Yasuo Miura, Masaki Iwasa, Aya Fujishiro, Noriko Sugino, Sumie Fujii, Yoko Nakagawa, Atsushi Sato, Asumi Yokota, Hideyo Hirai, Tatsuo Ichinohe, Akifumi Kondo Takaori, Taira Maekawa., 58th Annual Meeting of the American Society of Hematology, 2016/12/04, Without Invitation, English
  27. Comparison of Reduced-Intensity Conditioning with Fludarabine/Busulfan and Fludarabine/Melphalan in Patients 50 Years or Older., Koji Kawamura, Shinichi Kako, Shuichi Mizuta, Ken Ishiyama, Jun Aoki, Shingo Yano, Takahiro Fukuda, Naoyuki Uchida, Yukiyasu Ozawa, Tetsuya Eto, Koji Iwato, Tatsuo Ichinohe, Yoshiko Atsuta, Yoshinobu Kanda., 2016/12/04, Without Invitation, English
  28. Hideki Nakasone, Kimikazu Yakushijin, Shigeo Fuji, Makoto Onizuka, Akihito Shinohara, Kazuteru Ohashi, Koichi Miyamura, Naoyuki Uchida, Minoko Takanashi, Tatsuo Ichinohe, Yoshiko Atsuta, Takahiro Fukuda, Masao Ogata., Impact of Total Body Irradiation on Successful Neutrophil Engraftment in Unrelated Bone Marrow or Cord Blood Transplantation., 58th Annual Meeting of the American Society of Hematology, 2016/12/04, Without Invitation, English
  29. Impact of the Presence of HLA 1-Locus Mismatch and the Use of Thymoglobulin in Unrelated Bone Marrow Transplantation., Koji Kawamura, Junya Kanda, Shigeo Fuji, Kosuke Yoshioka, Yukiyasu Ozawa, Takahiro Fukuda, Naoyuki Uchida, Koji Iwato, Tatsuo Ichinohe, Yoshiko Atsuta, Yoshinobu Kanda., 58th Annual Meeting of the American Society of Hematology, 2016/12/05, Without Invitation, English
  30. T Cells Bearing Anti-CD19-and/or Anti-CD38-Chimeric Antigen Receptors Effectively Abrogate Primary Double-Hit Lymphoma Cells., Keichiro Mihara, Tetsumi Yoshida, Yoshifumi Takei, Naomi Sasaki, Yoshihiro Takihara, Tatsuo Ichinohe., 58th Annual Meeting of the American Society of Hematology, 2016/12/05, Without Invitation, English
  31. Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia Harboring t(7;l l)(p15;p15)., Kaito Harada, Noriko Doki, Jun Aoki, Jinichi Mori, Shinichiro Machida, Yuho Najima, Naoyuki Uchida, Takahiro Fukuda, Heiwa Kanamori, Hiroyasu Ogawa, Tatsuo Ichinohe, Yoshiko Atsuta, Shingo Yano., 58th Annual Meeting of the American Society of Hematology, 2016/12/05, Without Invitation, English
  32. Impact of the presence of HLA 1-locus mismatch and the use of ATG in unrelated transplantation., Koji Kawamura, Junya Kanda, Shigeo Fiji, Kosuke Yoshioka, Takahiro Fukuda, Yukiyasu Ozawa, Koji Iwato, Naoyuki Uchida, Tetsuya Eto, Tatsuo Ichinohe, Yoshiko Atsuta, Yoshinobu Kanda., 2016/10/13, Without Invitation, Japanese
  33. Human bone marrow mesenchymal stromal/stem cells modulate IMiDs-induced differentiation of HSPCs., Sumie Fuji, Yasuo Miura, Masaki Iwasa, Aya Fujishiro, Noriko Sugino, Atsushi Sato, Asumi Yokota, Hideyo, Hirai, Akifumi Takaori-Kondo, Tatsuo Ichinohe, Taira Maekawa., 2016/10/13, Without Invitation, Japanese
  34. Pomalidomide + low-dose dexamethasone for Japanese with relapsed/refractory multiple myeloma (RRMM)., Shinichiro Okamoto, Shotaro Hagiwara, Kosei Matsue, Shinsuke Iida, Kazutaka Sunami, Takuya Komeno, Kenshi Suzuki, Kiyoshi Ando, Masafumi Taniwaki, Kensei Tobinai, Takaaki Chou, Hitomi Kaneko, Hiromi Iwasaki, Chie Uemura, Hiromi Tamakoshi, Mohammed H. Zaki, Thomas Doerr, Yoshiaki Kuroda, Tatsuo Ichinohe., 2016/10/13, Without Invitation, Japanese
  35. Low-dose thymoglobulin as second-line treatment for steroid-resistant acute GVHD: a JSHCT analysis., Makoto Murata, Kazuhiro, Ikegame, Yoshihisa Morishita, Hiroyasu Ogawa, Hirohisa Nakamae, Takashi Ikeda, Tetsuya Nishida, Masami Inoue, Tetsuya Eto, Tatsuo Ichinohe, Yoshiko Atsuta, Takanori Teshima., 2016/10/13, Without Invitation, Japanese
  36. An exploratory research for the GVHD prophylaxis after conventional CBT for adult leukemia., Seitaro Terakura, Makoto Murata, Rika Sakai, Takuhiro Yamaguchi, Satoshi Takahashi, Naoyuki Uchida, Yasushi Onishi, Kazuteru Ohashi, Yukiyasu Ozawa, Heiwa Kanamori, Hiroki Yamaguchi, Tatsuo Ichinohe, Minoko Takanashi, Yoshiko Atsuta, Takanori Teshima., 2016/10/13, Without Invitation, Japanese
  37. Impact of der (1;7) (q10;p10) and -7/del (7q) on the prognostic value after allo-HSCT in MDS., Hidehiro Itonaga, Ken Ishiyama, Jun Aoki, Kazunari Aoki, Takayuki Ishikawa, Kazuteru Ohashi, Takahiro Fukuda, Yukiyasu Ozawa, Naoki Kobayashi, Naoyuki Uchida, Tetsuya Eto, Minoko Takanashi, Tatsuo Ichinohe, Yoshiko Atsuta, Yasushi Miyazaki., 2016/10/14, Without Invitation, Japanese
  38. Clinical implications of t(11;14), t(4;14), and del17p in myeloma patients treated with ASCT., Hiroyuki Takamatsu, Takeshi Yamashita, Shingo Kurahashi, Takayuki Saitoh, Tadakazu Kondo, Takeshi Maeda, Koji Kawamura, Toshihiro Miyamoto, Sumihisa Honda, Tatsuo Ichinohe, Yoshiko Atsuta, Kazutaka Sunami., 2016/10/14, Without Invitation, Japanese
  39. Impact of TBI on engraftment and non-relapse mortality in unrelated HCT., Hideki Nakasone, Kimikazu Yakushijin, Shigeo Fuji, Makoto Onizuka, Akihito Shinohara, Takeshi Hagino, Koichi Miyamura, Naoyuki Uchida, Minoko Takanashi, Tatsuo Ichinohe, Takahiro Fukuda, Yoshiko Atsuta, Masao Ogata., 2016/10/14, Without Invitation, Japanese
  40. Comparison of reduced-intensity conditioning with fludarabine/busulfan and fludarabine/melphalan., Koji Kawamura, Shinichi Kato, Shuichi Mizuta, Ken Ishiyama, Jun Aoki, Shingo Yano, Takahiro Fukuda, Naoyuki Uchida, Koji Iwato, Tetsuya Eto, Ken-Ichi Matsuoka, Tatsuo Ichinohe, Yoshiko Atsuta, Yoshinobu Kanda., 2016/10/14, Without Invitation, Japanese
  41. Autologous HCT for APL during second CR before and after the introduction of arsenic trioxide., Masamitsu Yanada, Shingo Yano, Heiwa Kanamori, Moritaka Gotoh, Nobuhiko Emi, Kyoko Watakabe, Mineo Kurokawa, Akinori Nishikawa, Yoshiko Atsuta, Tatsuo Ichinohe, Akiyoshi Takami., 2016/10/14, Without Invitation, Japanese
  42. Outcomes and risk factors with stem cell transplantation for therapy-related myeloid neoplasms., Michiko Kida, Kensuke Usuki, Naoyuki Uchida, Takahiro Fukuda, Koji Iwato, Ken-Ichi Matsuoka, Tetsuya Eto, Tatsuo Ichinohe, Yoshiko Atsuta, Minoko Takanashi, Akiyoshi Takami, Yasushi Miyazaki, Shingo Yano, Ken Ishiyawa., 2016/10/14, Without Invitation, Japanese
  43. Stem cell memory T-cells are a reservoir of functional T-cells highly shared among individuals., Takahiko Miyama, Takakaza Kawase, Kazutaka Kitaura, Ren Chishaki, Masashi Shibata, Kumi Oshima, Hiroshi Hamana, Hiroyuki Kishi, Kiyotaka Kuzushima, Hiroh Saji, Ryuji Suzuki, Tatsuo Ichinohe., 2016/10/14, Without Invitation, Japanese
  44. Thrombocytopenia in pregnancy: Analysis of 92 pregnancies in 70 women., Sayaka Sugihara, Tatsuo Ichinohe., 2016/10/14, Without Invitation, Japanese
  45. Vitamin K2 supports hematopoiesis through acting on human bone marrow mesenchymal stromal/stem cells., Aya Fujishiro, Yasuo Miura, Masaki Iwasa, Sumie Fujii, Noriko Sugino, Atsushi Sato, Asumi Yokota, Hideyo Hirai, Akira Andoh, Kaoru Tohyama, Tatsuo Ichinohe, Taira Maekawa., 2016/10/14, Without Invitation, Japanese
  46. Role of RIC allogeneic HCT in older patients with AML, Satoshi Yamasaki, Akihiro Hirakawa, Jun Aoki, Naoyuki Uchida, Takahiro Fukuda, Hiroyasu Ogawa, Kazuteru Ohashi, Tadakazu Kondo, Tetsuya Eto, Heiwa Kanamori, Hirokazu Okumura, Koji Iwato, Tatsuo Ichinohe, Junya Kanda, Makoto Onizuka, Yachiyo Kuwatsuka, Masamitsu Yanada, Yoshiko Atsuta, Akiyoshi Takami, Shingo Yano., 2016/10/15, Without Invitation, Japanese
  47. Anti-CD38 chimeric antigen receptor T cells effectively abrogate primary double-hit lymphoma cells., Keichiro Mihara, Tetsumi Yoshida, Naomi Sasaki, Yoshihiro Takihara, Tatsuo Ichinohe., 2016/10/15, Without Invitation, Japanese
  48. Next-generation sequencing-based immunobioinformatics: toward a comprehensive understanding of the human immune system., Tatsuo Ichinohe, The 50th Congress of Japanese Association of Germfree Life and Gnotobiology and The 39th Congress of the Society for Microbial Ecology and Disease, 2017/06/09, With Invitation, English, Tokyo
  49. Significance of plasma citrulline levels as a predictive biomarker for intestinal mucosal injury during the early phase of hematopoietic cell transplantation., Noriyasu Fukushima, Satoshi Tomiyasu, Yoshinori Uji, Masako Yokoo, Takero Shindo, Yasushi Kubota, Toshihiko Ando, Kensuke Kojima, Eizaburo Sueoka, Tatsuo Ichinohe, Shinya Kimura, 2017/06/08, Without Invitation, English, Tokyo
  50. Landscape of immune reconstitution after allogeneic hematopoietic cell transplantation is superdominated by distinct T cell populations bearing T-cell receptor clonotypes shared among different individuals., Takahiko Miyama, Takakazu Kawase, Yasuko Honjo, Kazutaka Kitaura, Tadasu Shin-I, Ryuji Suzuki and Tatsuo Ichinohe, Takakazu Kawase, Yasuko Honjo, Kazutaka Kitaura, Tadasu Shin-I, Ryuji Suzuki and Tatsuo Ichinohe, 59th Annual Meeting of the American Society of Hematology, 2017/12/11, Without Invitation, English, Atlanta, GA, U.S.A.
  51. Human bone marrow mesenchymal stromal/stem cell-derived extracellular vesicles ameliorate graft-versus-host diseases-related manifestations., Sumie Fujii, Yasuo Miura, Aya Fujishiro, Takero Shindo, Yutaka Shimazu, Hideyo Hirai, Akifymi-Takaori-Kondo, Tatsuo Ichinohe, Taira Maekawa, 59th Annual Meeting of the American Society of Hematology, 2017/12/11, Without Invitation, English, Atlanta, GA, U.S.A.
  52. Safety and efficacy of once-daily intravenous busulfan in allogeneic transplantation: a matched-pair analysis., Shinichi Kako, Shin-ichiro Fujiwara, Miki Sato, Shun-ichi Kimura, Hideki Nakasone, Kazuteru Ohashi, Michihiro Hidaka, Tetsuo Maeda, Takanobu Morishita, Ritsuro Suzuki, Takahiro Fukuda, Tatsuo Ichinohe, Mio Kurata Yoshiko Atsuta, Yoshinobu Kanda, 59th Annual Meeting of the American Society of Hematology, 2017/12/10, Without Invitation, English, Atlanta, GA, U.S.A.
  53. Melphalan dose in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation with reduced-intensity fludarabine and melphalan., Kaito Harada, Shinichiro Machida, Masamitsu Yanada, Heiwa Kanamori, Makoto Onizuka, Yukiyasu Ozawa, Hikaru Kobayashi, Masashi Sawa, Junya Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Shingo Yano, 59th Annual Meeting of the American Society of Hematology, 2017/12/10, Without Invitation, English, Atlanta, GA, U.S.A.
  54. Rearrangement can predicts prognosis of diffuse large B-cell lymphoma in association with CDC25A overexpression., Yoshida T, Mihara K, Ohtaki M, Ohno Y, Takihara Y, Shiroma N, Arihiro K, Takei Y, Sasaki N, Ichinohe T, 2018 ASH Meeting on Lymphoma Biology, 2018/08/02, Without Invitation, English, Chantilly, VA, U.S.A.
  55. Prediction of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation using a matching learning algorithm., Arai Y, Kondo T, Fuse K, Shibasaki Y, Masuko M, Sugita J, Teshima T, Uchida N, Fukuda T, Ohashi T, Ozawa Y, Ichinohe T, Kanda Y, Atsuta Y, 60th Annual Meeting of the American Society of Hematology, 2018/12/01, Without Invitation, English, American Society of Hematology, San Diego CA, U.S.A.
  56. Characterization of novel major histocompatibility complex genes in zebrafish., Honjo Y, Ichinohe T, Nanopore community meeting 2018, 2018/11/28, Without Invitation, English, San Fransisco, CA, USA
  57. Risk factors and predictive scoring system for post-transplant lymphoproliferative disorder after haeamtopoietic stem cell transplantation., Fujimoto A, Hiramoto N, Yamasaki S, Inamoto Y, Uchida N, Maeda T, Mori T, Kanda Y, Kondo T, Tanaka J, Ichinohe T, Atsuta Y, Ogata M, Suzuki R, 60th Annual Meeting of the American Society of Hematology, 2018/12/01, Without Invitation, English, American Society of Hematology, San Diego CA, U.S.A.
  58. Impact of homozygous conserved extended HLA haplotypes on cord blood transplantation: implications for induced pluripotent stem cell banking and transplantation., Morishima Y, Morishima S, Murata M, Arima N, Uchida N, Ohno Y, takahashi S, Matsuhashi Y, Onizuka M, Eto T, Atsuta Y, Fukuda T, Ichinohe T, Kato S, Kanda J, 60th Annual Meeting of the American Society of Hematology, 2018/12/01, Without Invitation, English, American Society of Hematology, San Diego CA, U.S.A.
  59. Reduced-intensity allogeneic HSCT for children and adolescents/young adults with CML. A study from the Adult and Pediatric CML Workinng Group of the Japan Society for Hematopoietic Cell Transplantation., Shimada H, Tanizawa A, Kondo T, Muramatsu H, Yasui M, Tojo A, Nagamura-Inoue T, Eto T, Igarashi A, Kanamori H, Sato M, Noguchi M, Ichinohe T, Inoue M, Kato K, Atsuta Y, Ohashi K, 60th Annual Meeting of the American Society of Hematology, 2018/12/02, Without Invitation, English, American Society of Hematology,, San Diego CA, U.S.A.
  60. Efficacy and safety of autologous stem cell transplantation in elderly patients with multiple myeloma in the era of novel agents., Mizuno S, Kawamura K, Hanamura I, Sunami K, Mori T, Nakamura F, Iida S, Nakazawa H, Makita M, Kako S, Sawa M, Ueda Y, Takahashi H, Kanda Y, Ichinohe T, Atsuta Y, Takamatsu H, 60th Annual Meeting of the American Society of Hematology, 2018/12/02, Without Invitation, English, American Society of Hematology,, San Diego CA, U.S.A.
  61. Epidemiology of second allogenneic hematopoietic stem cell transplantation for patients with relapsed myelodysplastic syndrome., Shimomura Y, Hara M, Tachibana T, Ohashi K, Ozawa Y, Eto T, Uchida N, Mori T, Kanda J, Ichinohe T, Atsuta Y, Ichikawa T, Ishiyama K, 60th Annual Meeting of the American Society of Hematology, 2018/12/02, Without Invitation, Japanese, American Society of Hematology, an Diego CA, U.S.A.
  62. Effect of haplotype matching on outcomes after adult single cord blood transplantation., Kanda J, Kawase T, Tanaka H, Uchida N, Nagafuji K, Matsuhashi Y, Ohno Y, Onizuka M, Tanaka J, Ichinohe T, Atsuta Y., 60th Annual Meeting of the American Society of Hematology,, 2018/12/02, Without Invitation, English, American Society of Hematology, San Diego CA, U.S.A.
  63. Mixed chimerism and secondary engraftment failure in allogeneic transplantation for aplastic anemia., Kako S, Yamazaki H, Ohashi K, Ozawa Y, Ota S, Kanda Y, Maeda T, Kato J, Ishiyama K, Matsuoka K, Miyamoto T, Fukuda T, Ichinohe T, Atsuta Y, 60th Annual Meeting of the American Society of Hematology, 2018/12/03, Without Invitation, English, American Society of Hematology, San Diego CA, U.S.A.
  64. Who is the best donor for the second transplant?: HLA discrepancy between graft and host rather than that graft and first donor may impact the second transplant outcome from the JSHCT., Maeda Y, Ugai T, Kondo E, Ikegame K, Murata M, Uchida N, Miyamoto T, Takahashi S, Ohashi K, Nakamae H, Hirokawa M, Ichinohe T, Atsuta Y, Kanda Y, Kanda J, 60th Annual Meeting of the American Society of Hematology, 2018/12/03, Without Invitation, English, American Society of Hematology, San Diego CA, U.S.A.
  65. Comparable survival outcomes of haploidentical stem cell transplantation and unrelated bone marrow transplantation., Sugita J, Atsuta Y, Kurata M, Nakamae H, Kurita N, Ishiyama K, Shiratori S, Fukuda T, Ohashi K, Ozawa Y, Kanda J, Ichinohe T, Teshima T, 60th Annual Meeting of the American Society of Hematology, 2018/12/03, Without Invitation, English, American Society of Hematology, San Diego CA, U.S.A.
  66. Would bone marrow be associated with superior outcomes compared with peripheral blood for male patients with female donors in HLA-matched related transplantation?, Nakasone H, Kawamura K, Yakushijin K, Shinohara A, Kanamori H, Ohashi K, Fukuda T, Uchida N, Nakamae H, Kanda J, Ichinohe T, Atsuta Y, Inamoto Y, Seo S, Kimura F, Ogata M, 60th Annual Meeting of the American Society of Hematology, 2018/12/03, Without Invitation, Japanese, American Society of Hematology, San Diego CA, U.S.A.
  67. Effects of ionizing radiation on zebrafish early embryogenesis., Honjo Y, Ichinohe T, 3rd International symposium of the Network-type Joint Usage/Research Center for Radiation Dissaster Medical Science,, 2019/01/13, Without Invitation, English, Fukushima
  68. Trends in survival of AML patients undergoing related and unrelated HCT during the past two decades., Masamitsu Yanada, Masayoshi Masuko, Jinichi Mori, Jun Aoki, Shohei Mizuno, Takahiro Fukuda, Kazuhiko Kakihana, Yukiyasu Ozawa, Shuichi Ota, Heiwa Kanamori, Takehiko Mori, Hirohisa Nakamae, Tetsuya Eto, Souichi Shiratori, Tetsuo Maeda, Koji Iwato, Tatsuo Ichinohe, Yoshinobu Kanda, Junji Tanaka, Yoshiko Atsuta2, Shingo Yano, The 80th Annual Meeting of the Japanese Society of Hematology, 2018/10/12, Without Invitation, Japanese, Japanese Society of Hematology, Osaka
  69. Effect of allogeneic stem cell transplantation for patients with minimally differentiated AML., Satoshi Yamasaki, Jun Aoki, Jinichi Mori, Kaito Harada, Masashi Sawa, Naoyuki Uchida, Kazuteru Ohashi, Takahiro Fukuda, Shiro Koh, Heiwa Kanamori, Hiroyasu Ogawa, Hirokazu Okumura, Tatsuo Ichinohe, Yoshinobu Kanda, Junji Tanaka, Yoshiko Atsuta, Masamitsu Yanada, Shingo Yano, The 80th Annual Meeting of the Japanese Society of Hematology, 2018/10/12, Without Invitation, Japanese, Japanese Society of Hematology, Osaka
  70. Mixed chimerism and secondary engraftment failure in allogeneic transplantation for aplastic anemia., Shinichi Kako, Hirohito Yamazaki, Kazuteru Ohashi, Takahiko Sato, Shuichi Ota, Yoshinobu Kanda, Tetsuo Maeda, Jun Kato, Ken Ishiyama, Ken-Ichi Matsuoka, Toshihiro Miyamoto, Takahiro Fukuda, Tatsuo Ichinohe, Yoshiko Atsuta, Takehiko Mori, The 80th Annual Meeting of the Japanese Society of Hematology, 2018/10/12, Without Invitation, Japanese, Japanese Society of Hematology, Osaka
  71. Human BM-MSC derived extracellular vesicles modulate hematopoietic cells in GVHD mice., Fujii Sumie, Yasuo Miura, Aya Fujishiro, Takero Shindo, Yutaka Shimazu, Hideyo Hirai, Akifumi Takaori-Kondo, Tatsuo Ichinohe, Taira Maekawa, The 80th Annual Meeting of the Japanese Society of Hematology, 2018/10/12, Without Invitation, Japanese, Japanese Society of Hematology, Osaka
  72. Comprehensive T cell receptor (TCR) repertoire analysis of new T cell subsets with naive phenotype., Kisa Tanabe, Takakazu Kawase, Kazutaka Kitaura, Takahiko Miyama, Misaki Kobayashi, Mayu Sato, Takayuki Oda, Aoi Sakamoto, Kiyoto Tanaka, Kiyotaka Kuzushima, Kazuo Yamashita, Tadasu Shin-I, Ryuji Suzuki, Tatsuo Ichinohe, The 80th Annual Meeting of the Japanese Society of Hematology, 2018/10/12, Without Invitation, Japanese, Japanese Society of Hematology, Osaka
  73. Impact of PB vs BM on NRM and survival in female to male HGT from HLA-matched related donors., Hideki Nakasone, Koji Kawamura, Kimikazu Yakushijin, Akihito Shinohara, Heiwa Kanamori, Kazuteru Ohashi, Takahiro Fukuda, Naoyuki Uchida, Hirohisa Nakamae, Junya Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Yoshihiro Inamoto, Sachiko Seo, Fumihiko Kimurai, Masao Ogata, The 80th Annual Meeting of the Japanese Society of Hematology, 2018/10/12, Without Invitation, Japanese, Japanese Society of Hematology, Osaka
  74. Molecular cloning and characterization of endoglin gene in zebrafish., Kosuke Takano, Yasuko Honjo, Tatsuo Ichinohe, The 80th Annual Meeting of the Japanese Society of Hematology, 2018/10/12, Without Invitation, Japanese, Japanese Society of Hematology, Osaka
  75. Daratumumab-resistant 17p-deleted myeloma with extramedullary lesions successfully treated with DCEP., Kayo Toishigawa, Hisao Nagoshi, Keita Fujino, Taro Edahiro, Takahiko Miyama, Takehiko Morioka, Takakazu Kawase, Keichiro Mihara, Noriyasu Fukushima, Tatsuo Ichinohe, The 80th Annual Meeting of the Japanese Society of Hematology, 2018/10/12, Without Invitation, Japanese, Japanese Society of Hematology, Osaka
  76. GVHD free, relapse free survival in allogeneic transplantation for adult T cell leukemia/lymphoma., Hiroyuki Muranushi, Takero Shindo, Masakatsu Hishizawa, Masahito Tokunaga, Atsushi Wake, Nobuaki Nakano, Tetsuya Eto, Michihiro Hidaka, Kaname Miyashita, Toshihiro Miyamoto, Takahiro Fukuda, Tatsuo Ichinohe, Yoshiko Atsuta, Koji Kato, The 80th Annual Meeting of the Japanese Society of Hematology, 2018/10/13, Without Invitation, Japanese, Japanese Society of Hematology, Osaka
  77. HTLV-1-associated indolent CD8+ T cell proliferative disorder: is it a distinct clinical entity?, Taro Edahiro, Kayo Toishigawa, Takehiko Morioka, Takahiko Miyama, Hisao Nagoshi, Takakazu Kawase, Hiromi Nakagawa, Mitsunori Noma, Kazutaka Kitaura, Ryuji Suzuki, Keichiro Mihara, Noriyasu Fukushima, Tatsuo Ichinohe, The 80th Annual Meeting of the Japanese Society of Hematology, 2018/10/13, Without Invitation, Japanese, Japanese Society of Hematology, Osaka
  78. Elotuzumab-based combination therapy for multiple myeloma relapsed after autologous transplantation., Hisao Nagoshi, Jun Imagawa, Keichiro Mihara, Keita Fujino, Taro Edahiro, Kayo Toishigawa, Takahiko Miyama, Takehiko Morioka, Takakazu Kawase, Noriyasu Fukushima, Tatsuo Ichinohe, The 80th Annual Meeting of the Japanese Society of Hematology, 2018/10/13, Without Invitation, Japanese, Japanese Society of Hematology, Osaka
  79. Prognostic factors for adult single CBT among European and Japanese transplant cohorts., Junya Kanda, Hiromi Hayashi, Annalisa Ruggeri, Fumihiko Kimura, Fernanda Volt, Satoshi Takahashi, Myriam Labopin, Shinichi Kako, Karina Tozatto-Maio, Shingo Yano, Guillermo Sanz, Naoyuki Uchida, Maria Teresa Van Lint, Seiko Kato, Mohamad Mohty, Noel Milpied, Heiwa Kanamori, Jorge Sierra, Yuju Ohno, Riccardo Saccardi, Takahiro Fukuda, Tatsuo Ichinohe, Minoko Takanashi, Shinichiro Okamoto, Arnon Nagler, Yoshiko Atsuta, Eliane Gluckman, The 80th Annual Meeting of the Japanese Society of Hematology, 2018/10/14, Without Invitation, Japanese, Japanese Society of Hematology, Osaka
  80. Involvement of impaired ribosome biogenesis in leukemia development., Satoru Shinriki, Akinori Kanai, Akiko Nagamachi, Tatsuo Ichinohe, Toshiya Inaba, Hirotaka Matsui, The 80th Annual Meeting of the Japanese Society of Hematology, 2018/10/14, Without Invitation, Japanese, Japanese Society of Hematology, Osaka
  81. Primary adrenal diffuse large B cell lymphoma with concomitant CNS involvement at initial findings., Tetsumi Yoshida, Tatsuji Mino, Taro Edahiro, Hisao Nagoshi, Takakazu Kawase, Masatoshi Nishizawa, Noriyasu Fukushima, Tatsuo Ichinohe, The 82nd Annual Meeting of the Japanese Society of Hematology, 2020/10/10, Without Invitation, English, Japanese Society of Hematology, Kyoto(Virtual)
  82. The management of concurrent plasma cell myeloma and breast cancer., Taro Edahiro, Noriyasu Fukushima, Tetsumi Yoshida, Takakazu Kawase, Yoshiki Fujioka, Ren Chishaki, Tatsuji Mino, Sayaka Sugihara, Hisao Nagoshi, Ai Amioka, Masatoshi Nishizawa, Tatsuo Ichinohe, The 82nd Annual Meeting of the Japanese Society of Hematology, 2020/10/10, Without Invitation, English, Japanese Society of Hematology, Kyoto(Virtual)
  83. Treatment of TAFRO syndrome in a single institution., Aoi Sakamoto, Hisao Nagoshi, Keita Fujino, Taro Edahiro, Tetsumi Yoshida, Masatoshi Nishizawa, Takakazu Kawase, Hironori Kawano, Yoshiki Fujioka, Ren Chishaki, Tatsuji Mino, Sayaka Sugihara, Noriyasu Fukushima, Tatsuo Ichinohe, The 82nd Annual Meeting of the Japanese Society of Hematology, 2020/10/10, Without Invitation, English, Japanese Society of Hematology, Kyoto(Virtual)
  84. Treatment of idiopathic pneumonia syndrome following allo-HSCT with etanercept., Masatoshi Nishizawa, Taro Edahiro, Tatsuji Mino, Tetsumi Yoshida, Hisao Nagoshi, Takakazu Kawase, Noriyasu Fukushima, Tatsuo Ichinohe, The 82nd Annual Meeting of the Japanese Society of Hematology, 2020/10/10, Without Invitation, English, Japanese Society of Hematology, Kyoto(Virtual)
  85. Targeted knock-in of desired genes by use of Platinum TALEN for safer genome-edited T cell therapy., Nanaho Hasegawa, Takakazu Kawase, Nao Yoshida, Misaki Kobayashi, Kisa Tanabe, Yasuko Honjo, Kayo Toishigawa, Taro Edahiro, Hiroyuki Sato, Kenta Magoori, Ryuji Suzuki, Tetsushi Sakuma, Takashi Yamamoto, Masatoshi Nishizawa, Tatsuo Ichinohe, The 82nd Annual Meeting of the Japanese Society of Hematology, 2020/10/10, Without Invitation, Japanese, Japanese Society of Hematology, Kyoto(Virtual)
  86. Long-term results of reduced-intensity conditioning allogeneic HCT for older patinets with AML., Masamitsu Yanada, Takahiro Fukuda, Masatsugu Tanaka, Shuichi Ota, Takashi Toya, Takehiko Mori, Naoyuki Uchida, Yukiyasu Ozawa, Hirohisa Nakamae, Yoshinobu Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Shingo Yano, The 82nd Annual Meeting of the Japanese Society of Hematology, 2020/10/10, Without Invitation, Japanese, Japanese Society of Hematology, Kyoto(Virtual)
  87. Hematopoietic cell transplantation outcomes for children and AYA with RCMD., Asahito Hama, Daisuke Hasegawa, Motohiro Kato, Kenichiro Watanabe, Daiichiro Hasegawa, Yukiyasu Ozawa, Noriko Doi, Maho Sato, Yasushi Onishi, Yoshiyuki Kosaka, Yasuhiro Okamoto, Yoshiko Hashii, Koji Kato, Tatsuo Ichinohe, Yoshiko Atsuta, Jun Aoki, Nao Yoshida, The 82nd Annual Meeting of the Japanese Society of Hematology, 2020/10/10, Without Invitation, Japanese, Japanese Society of Hematology, Kyoto(Virtual)
  88. Prognostic anlysis for adult patients who received allo-HSCT at non-CR status., Momoko Nakamura, Yasuyuki Arai, Shigeki Hirabayashi, Tadakazu Kondo, Noriko Doki, Naoyuki Uchida, Takahiro Fukuda, Yukiyasu Ozawa, Masatsugu Tanaka, Makoto Onizuka, Tatsuo Ichinohe, Yoshiko Atsuta, Shinichi Kako, The 82nd Annual Meeting of the Japanese Society of Hematology, 2020/10/10, Without Invitation, Japanese, Japanese Society of Hematology, Kyoto(Virtual)
  89. The impact of individual HLAs on survival after allo-HSCT from HLA-matched donors for ATL patients., Satoko Morishima, Takero Shindo, Atae Utsunomiya, Takashi Ishida, Takahiro Fukuda, Nobuaki Nakano, Toshihiro Miyamoto, Tatsuo Ichinohe, Yoshiko Atsuta, Makoto Yoshimitsu, Koji Kato, The 82nd Annual Meeting of the Japanese Society of Hematology, 2020/10/10, Without Invitation, Japanese, Japanese Society of Hematology, Kyoto(Virtual)
  90. Response evaluation with single assement in multiple myeloma: a supllementary analysis of JCOG1105., Nobuhiko Nakamura, Dai Maruyama, Ryunosuke Machida, Tatsuo Ichinohe, Nobuyuki Takayama, Rie Ohba, Ken Ohmachi, Yoshitaka Imaizumi, Masahito Tokunaga, Hiroo Katsuya, Isao Yoshida, Kazutaka Sunami, Mitsutoshi Kurosawa, Nobuko Kubota, Hiroaki Morimoto, Harumi kato, Yoshihiro Kameoka, Yoshitoyo Kagami, Masahiro Kizaki, Kazuto Takeuchi, Wataru Munakata, Shinsuke Iidam, Hirokazu Nagai, The 82nd Annual Meeting of the Japanese Society of Hematology, 2020/10/10, Without Invitation, Japanese, Japanese Society of Hematology, Kyoto(Virtual)
  91. Updated comparison of outcomes of 7/8 allele matched UBMT and UCBT., Kotaro Miyao, Seitaro Terakura, Fumihiko Kimura, Takaaki Konuma, Koichi Miyamura, Masamitsu Yanada, Shiichi Kako, Satoko Morishima, Naoyuki Uchida, Noriko Doki, Yukiyasu Ozawa, Satoru Takada, Tetsuya Eto, Takafumi Kimura, Tatsuo Ichinohe, Yoshiko Atsuta, Junya Kanda, The 82nd Annual Meeting of the Japanese Society of Hematology, 2020/10/10, Without Invitation, Japanese, Japanese Society of Hematology, Kyoto(Virtual)
  92. Significance of marker chromosome in poorrisk AML after allogeneic hematopoietic transplantation., Fuse Kyoko, Masayoshi Masuko, Naoyuki Uchida, Noriko Doki, Takahiro Uchida, masatsugu Tanaka, Yukiyasu Ozawa, Kazuhiro Ikegame, Tetsuya Eto, Yoshinobu Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Masamitsu Yanada, The 82nd Annual Meeting of the Japanese Society of Hematology, 2020/10/10, Without Invitation, Japanese, Japanese Society of Hematology, Kyoto(Virtual)
  93. Outcome of hematopoietic stem cell transplantation for chronic active Epstein-Barr virus infection., Masahide Yamamoto, Maho Sato, Yasushi Onishi, Kenichi Matsuoka, Makoto Onizuka, Kenichiro Watanabe, Atsuhi Kikuta, Chizuko Sakashita, Thru Kobayshi, Tatsuo Ichinohe, Takahiro Fukuda, Masami Inoue, Yoshiko Atsuta, Ayako Arai, The 82nd Annual Meeting of the Japanese Society of Hematology, 2020/10/10, Without Invitation, Japanese, Japanese Society of Hematology, Kyoto(Virtual)
  94. Comparison of PBSCT and BMT in related transplantation for AML with reduced intensity conditioning., Takaya Mitsuyoshi, Yasuyuki Arai, Tadakazu Kondo, Takahito Kawata, Shigeki Hirabayashi, Junya Kanda, Takahiro Fukuda, Noriko Doki, Masatsugu Tanaka, Toshiro Kawakita, Naoyuki Uchida, Yukiyasu Ozawa, Junji Tanaka, Tatsuo Ichinohe, Yoshiko Atsuta, Masamitsu Yanada, The 82nd Annual Meeting of the Japanese Society of Hematology, 2020/10/10, Without Invitation, Japanese, Japanese Society of Hematology, Kyoto(Virtual)
  95. Allogeneic hematopoietic cell transplantation for adolescents and young adults with AML., Shohei Mizuno, Masamitsu Yanada, Koji Kawamura, Yasuyuki Arai, Tadakazu Kondo, Takahito Kawata, Naoyuki Uchida, Noriko Doki, Takahiro Fukuda, Masatsugu Tanaka, Yukiyasu Ozawa, Tetsuya Eto, Makoto Onizuka, Yoshinobu Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Akiyoshi Takami, The 82nd Annual Meeting of the Japanese Society of Hematology, 2020/10/10, Without Invitation, Japanese, Japanese Society of Hematology, Kyoto(Virtual)
  96. Cord blood transplantation for AMl of the elderly: a retrospective study of adult AML WG on JSHCT., Masamichi Isobe, Takkai Konuma, Masayoshi Masuko, Naoyuki Uchida, Shigesaburo Miyakoshi, Yasuhior Sugio, Tetsuya Eto, Masatsugu Tanaka, Yoshiko Matsuhashi, Norimichi Hattori, Makoto Onizuka, Takafumi Kimura, Tatsuo Ichinohe, Yoshiko Atsuta, Masamitsu Yanada, The 82nd Annual Meeting of the Japanese Society of Hematology, 2020/10/10, Without Invitation, Japanese, Japanese Society of Hematology, Kyoto(Virtual)
  97. High non-relapse mortality in CBT for adult ALL after conditioning with medium-dose VP16/CY/TBI., Mari Morita, Yasuyuki Arai, Tadakazu Kondo, Kaito Harada, Noriko Doki, Takahiro Fukuda, Hun Kato, Shuichi Ota, Yukiyasu Ozawa, Tatsuo Ichinohe, Takafumi Kimura, Yoshiko Atsuta, Shinchi Kako, The 82nd Annual Meeting of the Japanese Society of Hematology, 2020/10/10, Without Invitation, Japanese, Japanese Society of Hematology, Kyoto(Virtual)
  98. Immune dysregulation syndrome with de novo CTLA4 germline mutation responsive to abatacept therapy., Mariko Miyazaki, Hiroshi Ureshino, Syuichi Koarada, Masaharu Miyahara, Kazuharu Kamachi, Mariko Yoshimura, Masako Yokoo, Yasushi Kubota, Toshihiko Ando, Tatsuo Ichinohe, Tomohiro Morio, Shinya Kimura, The 82nd Annual Meeting of the Japanese Society of Hematology, 2020/10/10, Without Invitation, Japanese, Japanese Society of Hematology, Kyoto(Virtual)
  99. Significance of Marker Chromosome on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for AML., Kyoko Fuse, Masayoshi Masuko, Shohei Mizuno, Kaito Harada, Naoyuki Uchida, Noriko Doki, Takahiro Fukuda, Masatsugu Tanaka, Yukiyasu Ozawa, Kazuhiro Ikegame, Tetsuya Eto, Yoshinobu Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Masamitsu Yanada, The 62nd Annual Meeting of the American Society of Hematology, 2020/12/05, Without Invitation, English, American Society of Hematology, Virtual Congress
  100. Prognostic Analyses for Adult Relapsed / Refractory Acute Lymphoblastic Leukemia Patients Who Received First Allogenic Hematopoietic Stem Cell Transplantation., Momoko Nakamura, Yasuyuki Arai, Shigeki Hirabayashi, Tadakazu Kondo, Noriko Doki, Naoyuki Uchida, Takahiro Fukuda, Yukiyasu Ozawa, Masatsugu Tanaka, Makoto Onizuka, Tatsuo Ichinohe, Yoshiko Atsuta, Shinichi Kako, The 62nd Annual Meeting of the American Society of Hematology, 2020/12/05, Without Invitation, English, American Society of Hematology, Virtual Congress

External Funds

Acceptance Results of Competitive Funds

  1. Practical Research Project for Allergic Diseases and Immunology (Research on Technology of Medical Transplantation), 2015/04/01, 2016/03/31
  2. KAKENHI, 2014, 2016
  3. KAKENHI, Functional expression of HLA class Ib molecules in bone marrow-derived mesenchymal stromal cells and its implication for cellular immunotherapy, 2010, 2012
  4. KAKENHI, Development of effective hematopoietic stem cell transplantation/cellular immunotherapy for adult T-cell leukemia, 2005, 2009
  5. KAKENHI, 2000, 2001
  6. Health and Labour Sciences Research Grants, 2014/05/29, 2015/03/31
  7. KAKENHI, 2015, 2016
  8. KAKENHI, The potential role of HLA-G on transplantation immunity - examination of increasing recent reports -, 2010, 2013
  9. KAKENHI, 2015
  10. KAKENHI(Grant-in-Aid for Scientific Research (B)), 2017, 2019
  11. Practical Research Project for Allergic Diseases and Immunology (Research on Technology of Medical Transplantation) , 2017/04/01, 2018/03/31
  12. Practical Research Project for Allergic Diseases and Immunology (Research on Technology of Medical Transplantation) , 2017/04/01, 2018/03/31
  13. KAKENHI, Elucidation of structural basis of MHC-crossreactive T cell receptors : new insights into adaptive immunity, 2018, 2019

Social Activities

History as Committee Members

  1. Director, 2014/03, 2016/03, Japan Society for Hematopoietic Cell Transplantation (JSHCT)
  2. Director, 2016/03, 2018/02, Japan Society for Hematopoietic Cell Transplantation (JSHCT)
  3. Director, 2015/06, 2017/06, Japanese Data Center for Hematopoietic Cell Transplantation (JDCHCT)
  4. Appointed Director, 2014/09, 2016/10, Japasene Society for Histocompatibility and Immunogenetics (JSHI)
  5. Director, 2014/01, 2017/06, Japanese Association of Germfree Life and Gnotobiology (JAGG)

Organizing Academic Conferences, etc.

  1. 48th Congress of Japanese Association of Germlife and Gnotobiology (JAGG), President, 2015/01, 2015/01
  2. The Joint Congress of the 19th International Sumposium on Gnotobiology, President, 2017/06, 2017/06
  3. The 26th Annual Meeting of the Japan Society for Histocompatibility and Immunogenetics, President, 2017/10, 2017/10